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ABSTRACT OF DISSERTATION

THE EFFECT OF β-HYDROXY-β-METHYLBUTYRATE (HMB) SUPPLEMENTATION
ON NEUROMUSCULAR PERFORMANCE FOLLOWING FATIGUING EXERCISE IN
HEALTHY SUBJECTS

Supporters of a nutritional supplement, β-Hydroxy-β-Methylbutyrate (HMB)
supplementation, claim that it will increase the muscular strength gains and lean muscle
mass gains seen during a resistance training program. It has been suggested that HMB
supplementation does this by preventing muscle damage or by regenerating damaged
muscle cell membranes. However, no research has evaluated the effect of HMB
supplementation on low frequency fatigue. Therefore, the purpose of this study was to
determine if three weeks of HMB supplementation could attenuate the effects of low
frequency fatigue caused by eccentric muscle contractions of the tibialis anterior muscle.
A total of 33 healthy recreationally active subjects (18 males, 15 females; 23.2 ± 4.3 yr)
were recruited for this study. All subjects preformed 4 sets of 25 eccentric contractions
of the tibialis anterior muscle through a range of motion of 30 degrees. Recovery
measures were taken for 20 minutes after the fatigue protocol and at 48 and 96 hours of
recovery. The recovery measures included: Maximum voluntary contraction peak
torque, 10 Hz peak torque, 50 Hz peak torque, 10/50 Hz peak torque ratio, and EMG
measurements. Each subject served as their own control and limbs were randomly
assigned to pre-supplement or post-supplement limbs. Following the pre-supplement
fatigue protocol and recovery measures each subject completed three weeks of 3g/day
HMB supplementation. After the supplementation period the post-supplement fatigue
protocol was completed and recovery measures were taken. The 10 Hz peak torque
and the 10/50 Hz torque ratio in the pre-supplement limb was still significantly reduced at
the 96-hour recovery measurement time, indicating that it was still showing low

frequency muscle fatigue at this time. Furthermore, the post-supplement limb,
recovered from the fatigue protocol faster, and did not show any signs of low frequency
muscle fatigue at the 48-hour recovery measurement time. In addition the presupplement limb had significant maximum voluntary contraction torque deficit at the 48hour recovery measurement time and the post-supplement limb showed no significant
deficits. The main findings of this study were that three weeks of HMB supplementation
attenuated low frequency fatigue and maximum voluntary contraction torque reduction
after an eccentric fatigue protocol.

Keywords: Eccentric contractions; low frequency fatigue; tibialis anterior; dorsiflexors;
electrical stimulation

Jordon William Macht_____________________
Student’s Signature
7/18/2015_______________________________
Date

THE EFFECT OF β-HYDROXY-β-METHYLBUTYRATE (HMB) SUPPLEMENTATION
ON NEUROMUSCULAR PERFORMANCE FOLLOWING FATIGUING EXERCISE IN
HEALTHY SUBJECTS

By
Jordon William Macht

Jody Clasey, Ph.D___
Director of Dissertation
Heather Erwin, Ph.D______
Director of Graduate Studies

7/18/15________________
Date

ACKNOWLEDGMENTS
The following dissertation, while an individual work, benefited from the insights
and direction of several people. First, my Dissertation Chair, Dr. Jody Clasey, provided
great insights on the dissertation and research process. Also, Dr. Brock Symons,
provided insights and great feedback during the design of this research study. Next, I
would like to thank the rest of the Dissertation Committee, which includes Dr. Mark Abel
and Dr. Robert Shapiro. I would also like to thank the outside reader, Dr. Timothy
Butterfield for helping with this project and providing assistance with the equipment used
in this dissertation. Lastly, I want to greatly thank all of the subjects that volunteered
their time to take part in this study.

iii

TABLE OF CONTENTS

Acknowledgments…………………………………………….………………………………....iii
List of Tables………………………………………………………………………………….....vi
List of Figures……………………………………………………………………………………vii
Chapter I: Introduction………………………………………………………………………….1
Background………………………………………………………………………………1
Statement of the Problem………………………………………………………………2
Purpose…………………………………………………………………………………..3
Hypotheses………………………………………………………………………………3
Significance………………………………………………………………………………3
Delimitations……………………………………………………………………………..4
Limitations………………………………………………………………………………..4
Assumptions……………………………………………………………………………..4
Chapter II: Literature Review…………………………………………………………………..5
Defining Fatigue…………………………………………………………………………5
Central Fatigue Versus Peripheral Fatigue…………………………………………..5
Mechanisms of Fatigue…………………………………………………………………6
Low-Frequency Fatigue Versus High-Frequency Fatigue……………………….....8
Eccentric Muscle Contractions and Damage……………………………………….11
Rational of HMB Supplementation…………………………………………………..13
Mechanisms of Action of HMB……………………………………………………….15
Research Studies Involving HMB Supplementation……………………………….17
HMB Used in Cancer and AIDS Research…………………………………18
Research Studies That Reported No Effects
of HMB Supplementation…………………………………………………….19
Research Studies That Reported Positive Effects
of HMB Supplementation…………………………………………………….24
Conclusion……………………………………………………………………………...30
Chapter III: Methodology……………………………………………………………………...32
Subjects…………………………………………………………………………………32
Testing Procedures…………………………………………………………………....32
Anthropometric and Body Composition Measurements…………………..33
iv

Pre and Post Supplement Baseline Session with Fatigue Protocol……..33
Isometric Skeletal Muscle Strength…………………………………………34
Electromyography……………………………………………………………..35
Skeletal Muscle Activation………………………………………...…………35
Fatigue Protocol………………………………………………….……………36
Supplementation…………………………………………………….………..36
Statistical Analysis…………………………………………………………….36
Chapter IV: Results……………………………………………………………………………37
10/50 Hz Torque Ratio………………………………………………………………..37
10 Hz Peak Torque……………………………………………………………………38
50 Hz Peak Torque……………………………………………………………………39
MVC Torque……………………………………………………………………………40
TA EMG…………………………………………………………………………………41
Chapter V: Discussion………………………………………………………………………...48
Chapter VI: Summary…………………………………………………………………………54
Introduction……………………………………………………………………………..54
Research Questions and Hypotheses…………………………….…………………55
Discussion………………………………………………………………………………56
Conclusion……………………………………………………………………………...58
Future Research……………………………………………………………………….59
References………………………………………………………………………………………60
CURRICULUM VITAE…………………………………………………………………………66

v

LIST OF TABLES

Table 2.1: Summary of Studies that Reported no Effects of HMB Supplementation…..23
Table 2.2: Summary of Studies that Reported Positive Effects
of HMB Supplementation……………………………………………………………..29
Table 4.1: Subject Characteristic Measurements………………………………………….37
Table 4.2: Pre-Supplement and Post-Supplement Measures
for Fatigue Protocol and Recovery Period………………………………………….43
Table 4.2 (Continued): Pre-Supplement and Post-Supplement Measures
for Fatigue Protocol and Recovery Period.…………………..……………………..44

vi

LIST OF FIGURES

Figure 3.1: Study Overview………………………………………………………………..…34
Figure 3.2: Pre and Post- Supplement Baseline and Fatigue
Protocol Session Overview…………………………………………………..34
Figure 4.1: MVC Torque Measurements for
Pre and Post-Supplement Limbs……………………………………………45
Figure 4.2: 10 Hz Peak Torque Measurements for
Pre and Post-Supplement Limbs……………………………………………45
Figure 4.3: 50 Hz Peak Torque Measurements for
Pre and Post-Supplement Limbs……………………………………………46
Figure 4.4: 10/50 Hz Torque Ratio for
Pre and Post-Supplement Limbs……………………………………………46
Figure 4.5: TA EMG for Pre and Post-Supplement Limbs………………………………...47

vii

Chapter 1: Introduction
Background
When the human body participates in any strenuous physical activity there will be a
decline in muscular performance during that activity and this decline is commonly called
fatigue (2). Muscle fatigue can commonly be found in patients in hospitals, elderly
people, and even middle aged people performing their activities of daily living (2). This
type of fatigue is characterized by a loss of muscle strength that results from a decline in
both muscular force and velocity of contraction. In addition fatigue is reversible by rest,
and can be measured by a reduction in force, a change in electromyographic activity or
an exhaustion of contractile function (11, 14).
Low frequency fatigue (LFF) is muscular fatigue that occurs at low frequencies of
stimulation activation (34). Characteristics of LFF is the reduction in muscle force is
decreased at low stimulation frequencies, recovery of force is slow, taking hours or days,
and the effects remain in the absence of gross metabolic or electrical disturbance of the
muscle (2, 3, 25, 35). This form of fatigue can be seen after any form of intense
exercise and is a large contributor to the feeling of weakness in muscles after exercise
(25, 84).
The primary implication of LFF is the reduction of muscle force at low frequency
stimulation and is typically greater than 50% of rested values (25). Motor unit discharge
rates during voluntary skeletal muscle activation rarely exceed 30 Hz, so any voluntary
muscle contraction would be greatly affected by LFF (25). This would include any
strenuous activity, walking, stair climbing, and all other activities of daily living (25).
It has been shown that one of the causes of LFF is the reduced amount of calcium
(Ca2+) released from the sarcoplasmic reticulum (24). This reduces the amount of Ca2+
that can bind to troponin, reduces the amount of active muscle fibers, and therefore
reduces the amount of force that the whole muscle can produce (25). A decrease in
Ca2+ release affects muscle tension at low frequencies of stimulation to a much greater
degree than muscle tension at high frequencies (25, 84). It seems likely that there is
some degree of structural damage to one or more of the proteins or structures involved
in excitation contraction coupling and the long time course of LFF represents repair or
resynthesis of these proteins or structures (25, 84). In support of this muscle damage
explanation it has been shown that LFF is a prominent characteristic following eccentric
exercises and may be seen during the repair process if the muscle fiber was damaged
during this type of contraction (25).
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Eccentric muscle contractions produce more muscle damage than concentric or
static contractions (2, 6, 61). These types of contractions are part of everyday normal
activities such as, walking downstairs or lowering a heavy weight and the greater muscle
damage that is caused is not related to metabolic fatigue but, it is due to a mechanical
insult (6). In overstretched sarcomeres the sarcoplasmic reticulum could be damaged or
its connection with the transverse tubules might be altered (2) . The evidance for this is
the LFF that is seen after eccentric muscle contractions (6). This LFF has been found to
be caused by excitation contraction uncoupling and in particular a reduced amount of
Ca2+ release from the sarcoplasmic reticulum (2, 6, 61, 83).
A nutritional supplement that has gained attention recently is β-Hydroxy-βMethylbutyrate (HMB) and it claims to improve recovery following muscle damage. HMB
has been associated with increased isometric, isokinetic, and dynamic strength and has
been generalized across young, elderly, untrained, trained and clinically cachexic
conditions (88). HMB is a metabolite of the essential branch chain amino acid leucine
and is thought to act as an anticatabolic agent, minimizing protein breakdown and
damage to cells which may occur with intense exercise (72, 79, 92). It has been
suggested that HMB supplementation increases muscular strength and lean muscle
mass gains, seen during a resistance training program, by preventing muscle damage or
by regenerating damaged muscle cell membranes (26, 43, 46, 53, 66, 88).

Statement of the Problem
LFF can be seen after any form of activity and is a large contributor to the feeling
of weakness in muscles after exercise and force reduction is typically greater than 50%
of rested values (25, 84). In addition, recovery of force is slow, and can take hours or
days (2, 3, 25, 35). Motor unit discharge rates during voluntary skeletal muscle
activation rarely exceed 30 Hz, so any voluntary muscle contraction would be greatly
affected by LFF (25). This would include any strenuous activity, walking, stair climbing,
and all other activities of daily living (25).
HMB supplementation has been associated with increased isometric, isokinetic, and
dynamic strength and has been generalized across young, elderly, untrained, trained
and clinically cachexic conditions (88). HMB supplementation can potentially prevent
muscle damage or enhance regeneration of damaged muscle cell membranes (26, 43,
46, 53, 66, 88). So, HMB supplementation may be effective in reducing LFF caused by
2

muscle damage and to this date a research study has not been found investigating the
effects of HMB supplementation and the reduction of LFF. If supplementation with this
substance can be shown to reduce LFF, caused by fatiguing physical activity, then it
may provide a quicker recovery for recreational athletes, the general public, and people
suffering from long term illnesses.
Purpose
The purpose of this study was to determine if three weeks of HMB
supplementation could attenuate the effects of LFF caused by eccentric muscle
contractions in young healthy adults.
Hypotheses
Hypothesis 1 – There will be two distinct types of fatigue after the eccentric
fatigue protocol. This will include a high frequency fatigue, measured by the 50 Hz peak
torque which will recover faster than the low frequency fatigue, measured by the 10 Hz
peak torque.
Hypothesis 2 – HMB supplementation will reduce the recovery time of low
frequency fatigue following eccentric exercise. The 10/50 Hz torque ratio and 10 Hz
peak torque will recover toward baseline levels faster in the HMB supplemented limb.
Hypothesis 3 – HMB supplementation will reduce the recovery time of muscle
damage caused by eccentric exercise. The MVC torque will recover toward baseline
levels faster in the HMB supplemented limb.
Significance
The mechanisms of fatigue are complex and multiple mechanisms can influence
muscle fatigue at the same time. Based on scientific studies it has been concluded that
LFF is most likely caused by failure of excitation-contraction coupling or the reduction of
cross bridge force production (32). There have been many hypotheses and theories on
what causes LFF and over the years through different scientific experiments some of
these hypotheses have been disproven. But, there has not been any single theory that
has been proven to explain all of the variables involved in LFF nor have there been any
procedures or substances that have been shown to entirely block or completely
eliminate LFF. The contribution of this research is expected to be the first step in
3

discovering methods or substances that will reduce both LFF and muscle damage. In
addition, this research will add to the literature of the severity and time course of LFF.
This contribution will be significant because it will allow people to participate in their daily
activities without decreased ability due to LFF and without the discomfort of muscle
damage.

Delimitations
This study was delimited to recreationally active males and females between the
ages of 18-35. “Recreationally active” was defined as a person who was physically
active for 60 minutes per day, 3-5 days per week.
Limitations
A limitation of this study was that a direct measure of muscle damage was not
used after the fatigue protocol. Another limitation of this study was that the subject’s
physical activity and nutritional intake was not strictly controlled. The subjects were
instructed to maintain their same nutritional intake and activity level during the
supplementation and testing periods. In addition, a true control group or a placebo
group was not used for comparison in this study.
Assumptions
It was assumed that all subjects gave a maximal effort during all testing
procedures and that their nutritional intake and physical activity remained constant
throughout the entire study.

Copyright © Jordon William Macht 2015
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Chapter II: Literature Review

Defining Fatigue
The term fatigue is very hard to define. First, we must distinguish between
subjective fatigue and physiological fatigue. Subjective fatigue can be defined as
physical or mental weariness resulting from exertion and it is a feeling that a person
experiences (12). So, it is subjective and the amount of fatigue varies depending on the
person being tested and is very hard to measure accurately and consistently.
Physiological fatigue on the other hand is not subjective and is easier to measure.
There are many different definitions of physiological fatigue but, for the purpose of this
review it will be defined as the “failure to maintain the required or expected force” of a
particular task (32). This type of fatigue is characterized by a loss of muscle strength
that results from a decline in both muscular force and velocity of contraction, and is
reversible by rest (14). Muscular fatigue can be measured by a reduction in muscle
force, a change in electromyographic activity or an exhaustion of contractile function
(11).
Another problem with defining physiological fatigue is the question: when does
fatigue occur? It is accepted that fatigue is not the point of task failure or when muscles
become exhausted (11). But, it is a decrease in maximal force that the muscles can
produce and it develops soon after the onset of physical exercise (11).

Central Fatigue Versus Peripheral Fatigue
Physiological fatigue can be broken down into two components: central fatigue
and peripheral fatigue (32). Central fatigue is impaired muscular performance that
arises from the central nervous system (12). This type of fatigue may be affected during
voluntary exercise by emotions or other psychological factors (32). Central fatigue may
also be affected by descending motor pathways, interneurons, and motoneurons in the
central nervous system (brainstem and spinal cord) (32). A major problem in measuring
central fatigue is that very little is known about the neurons involved in the generation of
volitional effort (32). For this reason most of the experiments designed to test muscular
fatigue aim to limit the effects of central fatigue, by electrically stimulating muscles rather
than having the subject perform volitional contractions.
5

The second component of physiological fatigue is peripheral fatigue (32). This
type of fatigue occurs when one or several of the physiological processes that enable
the contractile proteins to generate force become impaired or reduced (11). Peripheral
fatigue occurs outside of the central nervous system and can be caused by reduced
impulse conduction in the motor axons and their terminals, reduced neuromuscular
transmission to the muscle, reduced conduction of impulses in the muscle fibers,
reduced excitation-contraction coupling (E-C coupling), or impairments in the contractile
process itself (11). There is no single cause of peripheral muscle fatigue, it can result
from multiple factors acting at various sites, and a combination of factors can be involved
(14). For the duration of this review the term fatigue will imply physiological peripheral
fatigue.
There are several methods that are used to induce and measure muscle fatigue.
A very common technique is to stimulate the muscle with an external electrical stimulus
(32). A muscle twitch is developed by a short burst of electrical activity and has been
used to evaluate post-fatigued whole muscles and muscle fibers (14). Some features
that can be seen in a post-fatigued muscle fiber or whole muscle are: reduced twitch
force, reduced whole muscle force, prolonged contraction and half-relaxation times, and
reductions in the peak rate of tension development (14). These changes in muscle
fibers will lead to a decline in muscular performance and will include reduced force
production, decreased velocity of muscle shortening, and slowed muscle relaxation (2).

Mechanisms of Fatigue
Before the mechanisms of fatigue are discussed a review of the events that
occur to cause muscle contraction will be given. This process starts in the central
nervous system that sends an action potential down the α-motoneuron (86). The action
potential travels down the motoneurons and reaches the nerve axon terminal, at this
time voltage-gated Ca2+ channels open and Ca2+ enters the axon terminal (86) . This
causes vesicles to migrate to the axon terminal end bud and release the
neurotransmitter acetylcholine into the synaptic cleft (86). Acetylcholine reaches the end
plate of the muscle fiber, binds with postsynaptic receptors, and causes a local
depolarization (86). This depolarization causes an action potential on the muscle fiber
by activating voltage-gated sodium and potassium channels (86). Next, acetylcholine is
6

removed from the synaptic cleft and the action potential is propagated along the surface
of the muscle fiber (86). At this point the process of excitation-contraction coupling (E-C
coupling) begins. As an action potential is propagated down the muscle fiber the first
step of E-C coupling is the action potential moves into the interior of the muscle fiber
through the T-tubules (32). This causes the voltage sensors, the dihydropyridine
receptors (DHPR), to signal the ryanodine receptors (RYRs) to open (32). When the
RYRs are open a rapid escape of calcium (Ca2+) from the sarcoplasmic reticulum (SR)
enters the cytosol of the muscle fiber (32). Some of the Ca2+ in the muscle fiber cytosol
combines with troponin on the actin filaments which starts the cross bridge cycle that
produces muscle shortening and force (32). Once the action potential has ended, Ca2+
is pumped back into the SR by a membrane-bound Ca2+ ATPase and breaks the Ca2+
troponin complex which stops the cross bridge cycle (32).
Any abnormalities in any of the process just described have the possibility to
contribute to muscle fatigue. The mechanisms of fatigue are complex and multiple
mechanisms can affect muscle fatigue at the same time. Based on scientific studies it
has been concluded that muscle fatigue is most likely caused by failure of E-C coupling
or the reduction of cross bridge force production (32).
The first way that fatigue can affect muscle force during E-C coupling is by
reducing the amount of Ca2+ that is released from the RYR into the muscle fiber cytosol
(32). If a smaller amount of Ca2+ is released, then a smaller number of cross bridges will
be activated. It has been shown that the concentration of inorganic phosphate (Pi)
increases in the muscle fiber during muscle contractions (2). This is because the
breakdown of phosphocreatine (PCr) to creatine (Cr) and Pi is essential to produce ATP
rapidly for muscle contraction (2). It has also been shown that an increase in Pi in the
muscle fiber reduces Ca2+ release and therefore reduces cross bridge cycling and force
production (2). This type of muscle fatigue can be reversed by agents such as caffeine,
which opens the RYR and allows a greater amount of Ca2+ to enter the muscle fiber (2).
Another way that the increased Pi concentration can influence muscle force is by
slowing down the rate of the membrane-bound Ca2+ ATPase (2). This will slow down the
removal of Ca2+ from the muscle fiber back into the SR (2). This will in turn slow down
the relaxation rate of the cross bridge cycles and can delay the next cycle which may
contribute to muscle fatigue (2).
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Fatigue can also affect E-C coupling by a reduction in Ca2+ sensitivity (32).
Reduced Ca2+ sensitivity is a condition where force at a given free Ca2+ concentration is
lowered (32). So, in this case it is not the Ca2+ release that is the problem but, it is the
fact that not as much force is produced from the given Ca2+ release. In other words it
would take more Ca2+ release for the same amount of force production. The
accumulation of Pi is also thought to reduce Ca2+ sensitivity in a fatiguing muscle (2).
Another area that fatigue can influence force production is during the cross
bridge cycle (14). It has been shown that there is a slower dissociation of actin from
myosin in fatigued muscle fibers (14). This would slow down the rate of contraction of
the muscle fiber and therefore reduce the force production. This slowing of cross bridge
cycling is thought to be caused by an increase in hydrogen ions from the production of
lactic acid by the contracting muscles, and by the increase of Pi (14).
If a muscle fiber does not have ATP then the myosin heads cannot detach from
the actin molecule and rigor development can set in (84). This of course does not
happen in human muscle in vivo (84). So, it is thought that there may be a safety
mechanism built into muscles that reduces Ca2+ release when energy consumption can
no longer be met, to reduce the amount of ATP being consumed and protect the muscle
from going into rigor (84). This of course will also decrease the amount of force
produced and increase the amount of fatigue in the muscle.
There have been many hypotheses and theories on what causes muscle fatigue.
Over the years through different scientific experiments some of these hypotheses have
been disproven. But, there has not been one theory that has been proven to explain all
of the variables involved in muscle fatigue. There is a way to produce muscle fatigue by
sub maximal contractions that does not change any metabolite concentration a great
deal (32). Based on this and the close correspondence between force and intracellular
Ca2+ concentration, it has been determined that the likely cause of muscle fatigue occurs
somewhere in the E-C coupling phase of muscle contraction (32).
Low-Frequency Fatigue Versus High-Frequency Fatigue
Peripheral physiological muscle fatigue can also be sub grouped into two
different categories based on their physiological mechanisms (35, 37). These two
groups are low frequency fatigue at 5 to 30 Hz and high frequency fatigue at 50 to 100
Hz (35). High frequency fatigue is induced by high frequency stimulation and is
8

characterized by rapidly recovering loss of force at high frequencies (37). On the other
hand low frequency fatigue is induced by low frequency stimulation and characterized by
long term loss of force at low frequencies (37). High frequency fatigue recovers very
quickly usually within minutes after stimulation or exercise has stopped (35). Based on
the fast recovery of this type of fatigue the mechanisms are thought to be impaired
muscle fiber membrane excitation, which is associated with an accumulation of
potassium in the inter-fiber space or in the extracellular fluid contained in the transverse
tubular system (35).
The second type of peripheral physiological muscle fatigue is low frequency
fatigue (LFF). The characteristics of LFF are that muscle force is decreased most
severely at low stimulation frequencies, recovery of force is slow, taking hours or days,
and the effects remain in the absence of gross metabolic or electrical disturbance of the
muscle (2, 3, 25, 35). This form of fatigue can be seen after any form of intense
exercise but, is more pronounced after eccentric contractions, and is a large contributor
to the feeling of weakness in muscles after exercise (25, 84). Since eccentric
contractions cause LFF and its very slow recovery, it is possible that it is a consequence
of some form of damage caused by the generation of high forces within the muscle (22).
Also, LFF has been induced by voluntary contractions, high frequency stimulation (100
Hz), and low frequency stimulation (10-40 Hz) (25). This type of fatigue is typically
measured by recording torque response to different frequencies of electrical stimulation
(25). The change in the ratio of force production with 10-20 Hz stimulation compared to
the force production with 80-100 Hz stimulation is a fatigue index of LFF that is
commonly used (25). Any decrease in this ratio, compared before and after exposure to
a fatiguing protocol, is interpreted as LFF (25).
The primary implication of LFF is the reduction of muscle force at low frequency
stimulation (25). Observed force decrements with LFF in human skeletal muscles are
typically greater than 50% of rested values (25). Motor unit discharge rates during
voluntary skeletal muscle activation rarely exceed 30 Hz, so any voluntary muscle
contraction would be greatly affected by LFF (25). This would include any strenuous
activity, walking, stair climbing, and all other activities of daily living (25). This effect of
LFF on voluntary muscle contraction could result in higher activation of the central
nervous system, require the recruitment of a larger number of motor units or increased

9

firing frequency, and cause greater feelings of effort during repetitive activities and may
limit performance (25).
It is clear that the mechanisms of LFF is caused by disruption within the muscle
rather than in the nervous system because, during LFF the muscle electromyogram
appears normal and it has been shown to occur in isolated muscle fibers (2). Also, LFF
may not have a ionic or metabolic basis like other types of fast recovery fatigue because
it takes so long to subside (25). There is evidence that LFF is caused by a defect in E-C
coupling due to the fact that nearly maximal muscle tension can be achieved by high
frequency stimulus or the addition of caffeine (2). The point in E-C coupling that LFF
may affect is not known but, possible events include: failure of Ca2+ release from SR,
reduced Ca2+ sensitivity of the contractile proteins, reduced conduction of the action
potential in the T- tubules, and reduced Ca2+ reuptake by the SR (25, 84).
Westerblad et al. have demonstrated in mouse single muscle fibers that Ca2+
sensitivity of the contractile proteins is unchanged and Ca2+ release from the SR is
reduced at all stimulus frequencies during LFF (84). They also reported that Ca2+release
was uniform across the entire muscle fiber, suggesting the T-tubule conduction remains
adequate (84). In this experiment Ca2+ reuptake was moderately reduced, but it was
unlikely to be the cause of the reduced amount of Ca2+ in the muscle fiber (84). The
authors concluded that LFF is caused by a reduced Ca2+ release from the SR (84). This
reduced amount of Ca2+ from the SR reduces the amount of Ca2+ that can bind to
troponin, reduces the amount of active muscle fibers, and therefore reduces the amount
of force that the whole muscle can produce (25). The reduced Ca2+ release could be
caused by: failure of the action potential in the surface membrane, failure of T tubule
conduction, abnormal function of DHPR in the T tubules, or abnormal function of the
RYRs (85). Due to the long time course of recovery of LFF, which suggests that the
reduced Ca2+ release may last longer than 24 hours, it is likely that a structural change
involved in E-C coupling occurs and the long recovery time represents repair or
resynthesis of this change (85).
A decrease in Ca2+ release affects muscle tension at low frequencies of
stimulation to a much greater degree than muscle tension at high frequencies (25, 84).
This can be seen when the concentration of intracellular Ca2+ release is plotted against
the muscle tension produced (25). In this graph it can be seen that the Ca2+ release at
high frequency stimulation occurs at the plateau of the Ca2+-tension curve so, a change
10

in the intracellular Ca2+concentration would not yield a large change in the amount of
tension produced by the muscle (25, 84). On the other hand, low frequency stimulation
occurs on the steep portion of the Ca2+-tension curve and a small change in the
intracellular Ca2+ concentration would yield a large change in the muscle tension
produced (25, 84).
It has been shown that the most likely cause of LFF is reduced Ca2+ release from
the SR (2). There are many possibilities for the cause of this reduced Ca2+ release and
the most important evidence that needs to be considered is the long time course of LFF,
which suggests that reduced Ca2+ release can last for longer than 24 hours (25, 84).
With this in mind it seems likely that there is some degree of structural damage to one or
more of the proteins or structures involved in E-C coupling and the long time course of
LFF represents repair or resynthesis of these proteins or structures (25, 84). In support
of this muscle damage explanation it has been shown that LFF is a prominent
characteristic following eccentric exercises and may be seen during the repair process, if
the muscle fiber was damaged during this type of contraction (25).
Eccentric Muscle Contractions and Damage
Eccentric muscle contractions are lengthening muscle contractions or stretching
of contracting muscles and they occur when the imposed load is greater than the muscle
force generated (2, 45). Eccentric contractions produce more muscle damage than
concentric or static contractions (2, 6, 61). These types of contractions are part of
everyday normal activities such as, walking downstairs or lowering a heavy weight (2).
Just walking requires muscles to undergo repetitive cycles of concentric and eccentric
muscle actions (68). In general any movement of a joint that is controlled by an agonist
and antagonist muscle pair, one will be contracting eccentrically and the other will be
contracting concentrically (2). In physical activity if there is a large eccentric component
to the activity, weakness will be apparent during and immediately after the activity but,
pain, tenderness, swelling and stiffness develop more slowly and last much longer (2).
These latter symptoms are most prominent on the first or second days after the physical
activity and they are termed delayed onset muscle soreness (DOMS) (2). DOMS is
thought to start with an initial mechanical event, leading to microscopic disruptions within
the muscle fibers, which then lead to cell membrane damage and the loss of intracellular
Ca2+ homeostasis (4). The functional implications of this type of damage caused by
eccentric muscle contractions are significant and include a decreased joint range of
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motion, altered fatigability, muscle soreness, and decreased muscle shortening velocity,
but it is the prolonged strength loss that is the most widely recognized as the largest
restriction to physical activity (83).
After a bout of eccentric exercise muscle soreness appears 24 hours after
exercise and peaks at 2-3 days post-exercise (9). Soreness slowly dissipates and does
not fully subside until 8-10 days after exercise (9).

Swelling and edema have also been

suggested to cause soreness which is likely due to an increase in muscle pressure (9).
Muscle strength loss is dramatic immediately after eccentric muscle contractions,
recovers slowly, and by 10 days after exercise a deficit still remains (9). This strength
loss may be caused by damaged myofibrils, a change in neural activation patterns, or
sarcomeres stretched out by the performance of the lengthening actions (9). Sarcomere
length is not uniform over the length of the fiber because, shorter sarcomeres are found
toward the ends (9). If the lengthening actions pull some of the central sarcomeres
apart, the overlap between the actin and myosin filaments would be reduced, which
would reduce the maximal number of cross bridges, and reduce the amount of force
production (9). Another reason that force is reduced after eccentric contractions could
be the decline of Ca2+ release from the SR (9). If the SR is damaged due to the
lengthening contractions Ca2+ release would be reduced and the ability to generate
normal force levels would be impaired (9). Immediately after eccentric exercise range of
motion is decreased and the ability to fully contract the muscle is decreased and is not
restored until 10 days after the exercise (9). This could be because of the loss in muscle
strength and could be related to the overstretched sarcomeres or the decreased Ca2+
release from the SR (9).
Exercise protocols that use concentric muscle actions typically produce strength
losses of 10-30% immediately after exercise, with strength returning to baseline within
hours after exercise (8). Also, this type of muscle action does not produce damage and
since there is a fast restoration of force loss, the fatigue is generally considered to be
due to metabolic or neural factors (7). On the other hand high force eccentric exercise
protocols can often generate up to 50-65% loss of force generating capacity when
compared with pre-exercise values (8). Prolonged force loss after this type of muscle
contractions can typically last one to two weeks and is thought to be caused by initial
damage during the exercise and additional damage during the regeneration process (8).
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Maximal eccentric muscle contractions can produce greater output forces than
concentric and isometric muscle contractions but, they produce lower electromyographic
(EMG) activity (6). The amount of integrated electromyographic (IEMG) activity during
eccentric contractions have been shown to be approximately half that recorded during
concentric contractions at similar workloads (38). If the IEMG is taken to reflect the total
amount of muscle fiber activity, then during eccentric contractions about half the number
of fibers are being activated to generate a given tension when compared to concentric
contractions (38). Muscle damage caused by eccentric muscle contractions has been
documented directly by muscle biopsy samples and indirectly from losses in strength
and range of motion, increases in muscle soreness, and increases in muscle proteins,
such as creatine kinase (CK) and lactate dehydrogenase (LDH), in the blood as markers
for damage (64). Among these markers, change in force generating capacity is
considered to be the most reliable. As a muscle lengthens, the ability to generate
tension increases and a higher load is distributed among the same number of fibers,
resulting in a higher load per fiber ratio (6). Also, since during eccentric contractions
there are less active muscle fibers, the load per fiber ratio is increased when compared
to concentric contractions (11). The fact that soreness and swelling peaks 24-48 hours
post-exercise suggests that the initial damage may be exacerbated in the days after
exercise (6). Inflammation occurring after the initial insult is likely responsible for the
continued damage and may also function in the regeneration process (6).

Rational of HMB Supplementation
There have been many different methods and nutritional supplements that have
been used to attempt to reduce the effects of fatigue, increase fat free mass and
strength, and improve muscular performance, in an attempt to increase the results of
physical exercise. Recreational athletes and health conscious people are looking for a
way to get more out of their workout sessions to improve their body image or to increase
their physical fitness level (54). Billions of dollars are spent each year on nutritional
supplements and most of these supplements claim to reduce fat mass, increase fat free
mass, or help to increase muscular strength (58). The most popular performance
enhancing supplements are protein and amino acids because they are essential for the
synthesis of structural proteins and are involved in numerous metabolic pathways that
are associated with exercise (58). In particular, a great deal of attention has been paid
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to the three branched-chain amino acids, leucine, isoleucine, and valine (19). To
enhance the increase of muscle mass in the human body in response to an exercise
stimulus there has to be either an increase in protein synthesis or a decrease in protein
catabolism (73). Acute changes in amino acid metabolism caused by exercise are
largely catabolic with a net negative balance between the rates of protein synthesis and
protein breakdown (44). After exercise skeletal muscle remains in negative protein
balance until adequate protein and energy are available for recovery (44). This is the
reason why supplementation with protein and amino acids are very popular with people
who are active and who are trying to increase their gains from their workout programs.
Leucine is one of the most popular amino acids that people supplement with because of
its roles in protein metabolism, glucose homeostasis, insulin action, and recovery from
exercise (87).
During leucine metabolism, it is first transaminated to its ketoacid, αketoisocaproate (KIC) (78). At this point most of the KIC enters the mitochondria and is
oxidatively decarboxylated to isovaleryl-CoA by branched-chain α-ketoacid
dehydrogenase (78). But, a small amount of KIC (approximately 5%) is converted to βhydroxy-β-methylbutyrate (HMB) by KIC dioxygenase in the cytosol of the liver (Figure
2.4 – left side) (78). In total only approximately 2 to 10% of leucine oxidation proceeds
to HMB (13, 73). HMB is then converted to HMG-CoA which is converted to mevalonate
and finally cholesterol by the enzyme HMG-CoA reductase (42).
In vitro leucine and KIC are both proposed to decrease nitrogen and protein loss
by inhibiting protein breakdown (40). Also, leucine has been shown to stimulate protein
synthesis and inhibit protein degradation in skeletal muscle of intact rats (19). But,
animal and human studies have not shown an anabolic effect except in situations of
either severe stress or trauma in which proteolysis is greatly elevated (40). This
suggests that KIC and leucine are active only during periods of excessive catabolism or
that a further metabolic product of leucine and KIC may be responsible for the
anticatabolic effects of these compounds (40). HMB has recently gained attention as a
nutritional supplement and it claims to increase muscle strength, muscle size, and fat
oxidation (58, 70, 73, 77, 80, 88). It has also been associated with increased isometric,
isokinetic, and dynamic strength and has been generalized across young, elderly,
untrained, trained and clinically cachexic conditions (88).
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HMB is a metabolite of the essential branch chain amino acid leucine and is
thought to act as an anticatabolic agent, minimizing protein breakdown and damage to
cells which may occur with intense exercise (17, 21, 26, 46, 49, 50, 53, 55, 57, 58, 73,
80, 91). HMB is present in both plants and animal foods such as catfish and citrus fruits
in small amounts (0.3-0.4 g/d) are produced endogenously (13, 18, 54). Although HMB
can be synthesized endogenously from leucine, it would take approximately 60g of
leucine to reach an HMB dosage of 3 g/d, which is the recommended dosage for HMB
supplementation (13). To obtain 60g of leucine from the diet, one would have to
consume at least 600g of protein from high leucine containing foods such as eggs, dairy,
and meats (13). Since this is not practical, to reach higher levels of HMB in the body
requires nutritional supplementation (13). When supplemental HMB is consumed, HMB
peaks in circulation at one to two hours after supplementation and reaches baseline
levels by nine hours (13). Also, when HMB is supplemented at 1 to 6 g/d it was shown
that approximately 14 to 29% was excreted in the urine so, it appears that a majority of
supplemental HMB remains in the body (13).
HMB supplementation has been suggested to impart anticatabolic properties and
to reduce muscle damage based on reduced enzyme markers of muscle damage such
as creatine phosphokinase (CK), lactate dehydrogenase (LDH), and 3-methylhistidine
(3-MH) (17, 21, 55, 70). Based on this HMB has been hypothesized to be the metabolic
product of leucine and KIC that is responsible for the anticatabolic effects and to
facilitate an increase in muscle mass and strength gains when combined with resistance
training (53, 58).
Mechanisms of Action of HMB
The major claims that are made by promoters of HMB supplementation are that it
will increase the muscular strength gains and lean muscle mass gains seen during a
resistance training program (40). It has been suggested that HMB supplementation
does this by preventing muscle damage or by regenerating damaged muscle cell
membranes (26, 43, 46, 53, 66, 88). This anticatabolic effect has been suggested to be
achieved by two mechanisms (26, 40, 50). The first mechanism involves conversion of
HMB, in the cytosol of the liver, to β-hydroxy-β-methylglutarate-CoA (HMG-CoA) (26, 40,
50). HMG-CoA is then employed in cholesterol synthesis and could be rate limiting
when cholesterol synthesis is in high demand, such as during periods of rapid cell
growth or membrane repair that is seen with resistance training (17). Without
15

cholesterol, cells cannot experience normal growth so, most cells are capable of making
their own cholesterol (90). But, there are many steps involved in cholesterol
biosynthesis and much valuable cellular energy is utilized in the complex pathway to
produce cholesterol (90). Also, stressed or damaged muscle cells may not be able to
make sufficient HMG-CoA to support adequate cholesterol synthesis for cell functions
(41). Supplemental HMB therefore, may be a source of HMG-CoA in damaged muscle
cells to maintain adequate cholesterol synthesis and plasma membrane function (41). It
has also been proposed that HMB supplementation provides a saturating source of
cytosolic HMG-CoA for cholesterol synthesis and, in turn, allows for maximal cell growth
and function (72). This increase in cholesterol synthesis has not been shown to
increase blood lipid profiles (41). In fact, it has been shown that 3 to 8 weeks of HMB
supplementation decreased total cholesterol by 3.7% and LDL cholesterol by 5.7% (41).
The second mechanism is that HMB is polymerized and covalently binds with cell
membrane structures to enhance membrane integrity (49, 50). This increased integrity
may also be accomplished through the additional source of cholesterol provided by HMB
supplementation (46). It has been hypothesized that the de novo synthesized
cholesterol is used to support the cell membrane integrity and help prevent muscle
damage or used to regenerate damaged muscle cell membranes (26). Thus, HMB may
provide the necessary amount of HMG-CoA for cholesterol synthesis and membrane
protection that would then result in decreased muscle damage and quicker recovery
from resistance exercise (17). This is supported by studies that have demonstrated that
HMB supplementation has decreased markers of muscle damage following strenuous
exercise (17, 26, 40, 55). This could also be one reason that HMB supplementation
does not produce strength gains in subjects that are highly trained with resistance
exercises (66). This is because with resistance training protein turnover and resistance
exercise induced muscle damage are attenuated and HMB supplementation may not be
able to reduce them further (66). Also, local deficiencies in muscle cell cholesterol are
thought to occur due to cell hypertrophy (54). This could cause cell growth to decrease
due to inadequate cholesterol available for cell membrane synthesis (54). Therefore, a
larger supply of cholesterol for cell membrane synthesis, due to HMB supplementation,
could lead to further muscle hypertrophy and larger lean muscle gains (54).
A more recent review has postulated that HMB supplementation could have other
mechanisms (91). These mechanisms include an up regulation of IGF-I gene
expression in skeletal muscles, stimulation of protein synthesis by increasing the mTOR
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signaling pathway, and suppression of proteolysis by the inhibition of the UPP system
(91). It is established that IGF-I exerts an anabolic action in skeletal muscle, leading to
hypertrophy of muscle fibers (91). It has been observed that muscle IGF-I expression
was increased after a culture of myoblasts were exposed to HMB (13). It has also been
reported that IGF-I expression has been increased in whole animal models with HMB
supplementation (28, 57). The enzyme mTOR (mammalian target of rapamycin) is a
protein kinase that is involved in cell growth and HMB appears to act upon the mTOR
pathway but the mechanisms are not yet known (13, 91). HMB supplementation may
attenuate muscle protein losses through reduction of the UPP (91). The ubiquitinproteasome system is up regulated in catabolic states and HMB has been shown to
decrease the activity of this pathway, thereby possibly reducing protein degradation (13,
91). Also, changes in the rates of protein degradation rather than changes in rates of
protein synthesis are the principle means for altering protein levels in many physiological
and pathological conditions (73). These three possible mechanisms of HMB
supplementation have not been fully researched yet. Most of these studies have been
completed in animal models or single muscle fibers (13, 28). Further research is needed
into how HMB supplementation may affect muscle growth and protein degradation
through these three mechanisms.

Research Studies Involving HMB Supplementation
A meta-analysis conducted by Nissen and Sharp in 2003 reported that out of
about 250 substances marketed as dietary supplements, only creatine and HMB were
found to be effective in augmenting lean tissue gains with resistance training (43). In a
second meta-analysis conducted by Rowlands and Thomson it was reported that HMB
supplementation caused beneficial increases in lower body and overall average strength
in untrained lifters, and strength was not affected by HMB in trained lifters (65). In a third
review article Wilson et al. reported that many studies support the efficacy of HMB as an
effective ergogenic aid for athletes to decreases DOMS, markers of muscle damage,
and body fat, while increasing various markers of performance, including lean body
mass and strength in resistance trained athletes (87). Also, there were a number of
studies analyzed that did not support the efficiency of HMB supplementation (87). The
authors suggested that the conflicting results may in part be attributed to the variability in
humans, inadequate sample sizes, and methodological issues such as the specificity of
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testing conditions, cases of overtraining, elicitation of an inadequate training stimulus in
experienced participants, limited dependent variables, and short duration experiments
(87). But, the results of HBM supplementation does not yield any clear cut conclusions.
There have been human studies that have reported reduced muscle damage and upper
body strength gains in both previously untrained men and women (17, 40, 55, 80).
There have also been studies that have reported increases in muscle mass, muscle
strength, reduced muscle damage, and anaerobic properties in previously trained men
and women (26, 58, 77). HMB supplementation has also been shown to positively affect
strength, fat free mass, protein synthesis, and functionality in elderly men and women
(15, 82).
Vukovich et al. conducted a study to investigate the kinetics of HMB
supplementation (81). Plasma HMB peaked at about 120 nmol/L within 2.0 ± 0.4 hours
after consumption of one gram HMB and peaked at about 480 nmol/L within 1.0 ± 0.1 for
three grams of HMB consumed (81). These values remained stable for the next 90
minutes, at which there was a gradual decline until 9 hours after consumption at which
time values were not significantly different from baseline (81). The percent accumulation
of HMB in the urine reached a level of about 14% of the given dose following the
consumption of one gram of HMB and about 29% for a dose of three grams of HMB
(81). The authors concluded that with HMB supplementation, plasma HMB levels peak
between one and two hours and a small amount of HMB is excreted in the urine with the
remaining being retained in the body for further metabolism (81).
HMB Used in Cancer and AIDS Research
Patients with cancer induced weight loss show a depression of protein synthesis
in skeletal muscle and an increase in protein degradation, via the UPP pathway (74).
The cachexia syndrome is seen in a variety of conditions including: cancer, surgery,
trauma, sepsis, and AIDS (47). It is characterized by anorexia, weight loss, weakness,
anemia, edema, and skeletal muscle wasting (47). Cancer cachexia has been cited as
the most frequent cause of morbidity and mortality in patients with cancer and
maintenance of lean tissue mass should lead to improved survival and decreased
morbidity (36). Anabolic stimuli or an increase in calorie intake has been shown not to
increase lean body weight in cachectic patients which suggests that protein degradation
must be attenuated before muscle mass can increase (74). Recent studies have
indicated that HMB was capable of attenuating protein degradation in skeletal muscle of
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cachectic mice and also stimulated protein synthesis resulting in an increase in the
nonfat carcass mass (47, 74). The reduction in protein degradation was found to be
caused by down-regulating the increased expression of the UPP pathway in the
cachectic mice (74).
A study conducted by May et al. tested a combination of HMB, L-glutamine, and
L-arginine supplementation in cancer patients who demonstrated a weight loss of at
least 5% (36). It was reported that this combination increased both body mass and fat
free mass relative to the control group (36). Also, these changes were apparent as early
as 4 weeks after the start of supplementation (36). The authors concluded that this
combination likely provided the substrates necessary for the body to minimize wasting
and replenish lean body mass (36).
Just like in cancer patients, AIDS patients show a disproportionate loss of lean
tissue with a preservation of fat mass (5). Also, these patients consume adequate
amino acids and energy to support muscle maximal protein synthesis so, the problem of
wasting is probably due to an accelerated rate of muscle catabolism relative to protein
synthesis (5). A study conducted by Clark et al. showed through air displacement
plethysmography, computerized tomography of leg muscles, and measurements of
midarm circumferences that a combination of HMB, L-glutamine, and L-arginine
increased lean tissue in AIDS-wasted patients (5). The authors concluded that this
mixture favorably altered the rates of protein breakdown relative to protein synthesis and
resulted in net protein accumulation (5).
The loss of muscle mass in cancer cachexia appears to be caused by a tumor
product, proteolysis-inducing factor (PIF), which increases the UPP protein degradation
pathway (75). In two separate studies it was reported that HMB was an effective agent
for the management of muscle wasting in cancer induced protein degradation in murine
myotubes (10, 75). It was concluded in both studies that HMB produced these positive
effects by attenuation of PIF-induced protein degradation mediated through the UPP
pathway (10, 75).
Research Studies That Reported No Effects of HMB Supplementation
Not all research studies have shown favorable results associated with HMB
supplementation. In general authors have reported that HMB supplementation did not
have an effect on muscular strength, muscular endurance, or body composition in
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trained males (49, 50, 70). Also, short supplementation of HMB (less than 14 days) did
not show any benefit in recovery of muscle function after exercise induced muscle
damage or any other ergogenic responses in previously trained or untrained males (21,
46, 53).
There were five research studies found that used trained subjects and reported
no effects of HMB supplementation (Table 2.1). The first of these studies was
conducted by Ransone et al. and used Division I college football players as subjects
(62). The subjects in this study supplemented with 3g per day of HMB for 28 days (62).
During the supplementation period the subjects participated in a strength training and
cardiovascular training program four days per week (62). Strength exercises were
performed at 10 exercises per session, with 8-12 sets per exercise and 2-10 repetitions
per set (62). The authors reported that HMB supplementation did not alter muscular
strength, total body weight, or percent body fat in collegiate football players undergoing a
exercise program (62). It was concluded that HMB may be most effective when initiating
an exercise training program or increasing the workload of a training program (62).
The second HMB research study that involved trained athletes was conducted by
O’Connor and Crowe and elite male rugby players were used as subjects (50). In this
study aerobic power was tested using a 20 meter shuttle test and anaerobic capacity
was measured using a 60 second maximal cycle ergometer test (50). Pre and postsupplement measurements were separated by six weeks and the dosage was 3g per
day (50). It was reported that HMB supplementation did not alter aerobic or anaerobic
power in the subjects (50).
O’Connor and Crowe conducted another study using elite male rugby players
and HMB supplementation and used the same dosage and supplementation time period
(48). In this study muscular strength and endurance, leg power, and anthropometry
were measured pre and post-supplement (48). The authors reported no improvement in
muscular strength and endurance, leg power, or anthropometry with HMB
supplementation during a resistance training program (48). The authors concluded that
the benefits from HMB may be limited in well trained subjects, particularly those with a
resistance training background (48).
A study conducted by Kreider et al. examined the effects of HMB
supplementation during resistance training on markers of catabolism, body composition,
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and strength in experienced resistance trained males (29). The supplementation period
was 28 days and the dosage of HMB was 0, 3, or 6g per day for this study (29). Pre and
post supplementation measurements were taken and consisted of body composition,
venous and urine samples, and bench press and leg press maximal lifts (29). The
authors reported that no dosage of HMB affected markers of anabolic/catabolic status,
body composition, or gains in upper and lower body strength (29).
Slater et al. conducted a study with resistance trained males and 6 weeks
supplementation of 3g per day of HMB (69). Pre and post supplementation
measurements were taken and consisted of body composition, venous blood sample,
and 3 repetition maximum strength tests in the bench press, leg press, and chin-ups
(69). It was reported that HMB did not influence changes in strength or body
composition during resistance training in strength trained subjects (69).
A second group of studies were found that reported HMB supplementation did
not have any benefits and these studies all had supplementation periods less than 14
days (Table 2.1). The first of these studies was conducted by Paddon-Jones et al. and
the HMB supplementation was 40mg/kg bodyweight/day for 6 days (52). The exercise
protocol for this study was 24 maximal voluntary eccentric contractions of the elbow
flexors and pre and post-test measurements were taken (52). The measurements used
in this study were muscle soreness, upper arm girth, and isometric, concentric, and
eccentric torque (52). The authors reported that short-term supplementation with HMB
did not reduce the severity of muscle soreness or improve the recovery of muscle torque
following an acute bout of eccentric exercise (52).
Another short-term HMB supplementation study was conducted by Hoffman et al.
(20). In this study Division III college football players supplemented with 3g per day
HMB for 10 days during their preseason football training camp (20). Pre and postsupplementation measures were taken and included blood samples measured for
testosterone, cortisol, myoglobin, and creatine kinase, and a 30 second Wingate
anaerobic power test was used to measure peak power, mean power, and rate of fatigue
(20). The authors reported that short-term HMB supplementation did not attenuate
biochemical markers of muscle damage or improve anaerobic power in college football
players (20). The authors concluded that if HMB has any ergogenic benefit in
attenuating muscle damage, it is likely to be most effective in the untrained population
where the potential for muscle damage to occur during exercise is greatest (20).
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A third short-term HMB supplementation study was conducted by Nunan et al.
and subjects supplemented for 14 days with 3g per day HMB (46). Post-test measures
were taken 24, 48, and 72 hours after a 40-minute downhill run and consisted of midthigh girth, knee extensor range of motion, serum CK activity, isometric and concentric
torque, and a DOMS measure (46). The authors reported that HMB supplementation
had no effect on any of the indices of muscle damage but, there was a trend for a more
rapid recovery of isometric function (46).
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Table 2.1: Summary of Studies that Reported no Effects of HMB Supplementation
Authors

Subjects

Exercise Protocol
Strength training:
8-12 sets, 2-10
repetitions for
each exercise
Pre and post
measurements
only

Supplementation
Duration
28 Days

Dosage
3g Per day

6 Weeks

3g Per day

Ransone et al.
(62)

35 College
football
players

O’Connor and
Crowe (50)

27
Professional
rugby players

O’Connor and
Crowe (48)

30
Professional
rugby players

Pre and post
measurements
only – Subjects
continued normal
workout program

6 Weeks

3g Per day

Kreider et al.
(29)

40 Resistance
trained males

28 Days

0, 3, or 6g Per
day

Slater et al.
(69)

27 Resistance
trained males

6 Weeks

3g Per day

Paddon-Jones
et al. (52)

17 Nonresistance
trained males

6 Days

40mg/kg
bodyweight/day

Hoffman et al.
(20)

26 Division III
college
football
players

Pre and post
measurements
only – Subjects
continued normal
workout program
Pre and post
measurements
only – Subjects
continued normal
workout program
24 Maximal
voluntary
eccentric
contractions of the
elbow flexors
Preseason
football training
camp

10 Days

3g per day

Nunan et al.
(46)

14 Male
recreational
exercisers

40-minute
downhill run

14 Days

3g per day
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Outcome Measurements

Findings

1) 3-5 Repetition maximum lifts:
Bench press, power cleans, squats
2) Body composition: 3 site
skinfold
1) 20 meter shuttle aerobic power
test
2) 60 second cycle anaerobic
capacity test with blood lactate
1) 3 Repetition maximum: bench
press, deadlift, shoulder press,
prone row
2) Leg power: 10s maximal cycle
ergometer test
3) Anthropometric profile
1) Venous and urine sample
2) Maximum strength tests: Bench
press, leg press
3) Body composition

1) HMB did not alter muscular
strength, total body weight, or
percent body fat

1) Venous blood sample
2) Body composition
3) 3 repetition maximum strength
tests: Bench press, leg press,
chin-ups
1) Muscle soreness
2) Upper arm girth
3) Isometric, concentric, and
eccentric torque

1) HMB had no influence on
strength gains or body composition

1) Blood measures: Testosterone,
cortisol, myoglobin, creatine
kinase
2) Anaerobic power performance:
30 sec Wingate test
1) Mid-thigh girth
2) Knee range of motion
3) Serum CK activity
4) Isometric and concentric torque
5) DOMS measurement

1) HMB did not attenuate markers
of muscle damage or improve
anaerobic power performance

1) HMB did not alter aerobic or
anaerobic power

1) HMB did not alter muscular
strength and endurance, leg power,
or anthropometry

1) HMB did not affect markers of
anabolic/catabolic status, body
composition, or upper and lower
body strength

1) Short-term HMB did not reduce
muscle soreness or improve
recovery of muscle torque following
an acute bout of eccentric exercise

1) HMB had no effect on indices of
muscle damage
2) There was a trend for a more
rapid recovery of isometric function
with HMB

Research Studies That Reported Positive Effects of HMB Supplementation
HMB supplementation has been claimed to enhance gains in strength and lean
body mass associated with resistance training and it has been suggested to accomplish
this through a reduction in skeletal muscle damage (73). Because of this the research
studies that have reported positive effects of HMB are grouped into two categories, ones
that show a decrease in muscle damage and ones that show an increase in muscular
strength or lean body mass (Table 2.2).
The first study to report a decrease in muscle damage caused by HMB
supplementation was conducted by Ostaszewski et al. and rat and chicken whole
muscles were used in vitro (51). This study did not utilize an exercise protocol rather;
protein synthesis and breakdown were measured in whole muscles (51). The authors
reported that HMB decreased proteolysis in both rat and chicken muscles but did not
affect protein synthesis in either group (51).
A human resistance training study with HMB supplementation was conducted by
Panton et al. (56). In this study both males and females were used and they were
grouped into a trained or untrained groups (56). In the male group creatine
phosphokinase (CK), which is a marker for muscle damage, increased only 3.7% from
baseline in the HMB group but, showed a 15.2% increase in the placebo group during
the exercise protocol (56). For females, the difference in plasma CK was greater
between the HMB supplemented and placebo groups, with the HMB group decreasing
by 12.8% and the placebo increasing by 46.9% from baseline (56). In the male cohort
the HMB group had a greater increase in upper body strength compared to the placebo
(placebo 7.0 kg and HMB 9.9 kg; p  0.05) and the female HMB group showed a trend
toward a greater increase in upper body strength compared to the placebo (placebo 3.2
kg and HMB 5.1 kg; p=0.065) (56). The authors reported that the response from HMB
does not appear to be dependent on previous training levels and both males and
females appear to respond to HMB supplementation (56). The authors concluded that
both males and females in the HMB group, tended to have lower CK levels than the
placebo group indicating that less cell membrane damage may have occurred (56). It
has been postulated that supplementation with HMB can provide a source of HMG-CoA
for cholesterol synthesis and this cholesterol is an important constituent of cell
membranes (56). Therefore, supplementation with HMB may lead to increased
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membrane integrity by supplying a source for increased synthesis of intracellular
cholesterol during a time of need (56).
Van Someren et al. conducted a study using non-resistance trained males and
supplemented with both HMB and KIC for 14 days (79). The subjects performed an
exercise protocol designed to induce muscle damage using single arm biceps curls and
outcome measurements were taken at: pre-exercise, and 1h, 24h, 48h, and 72h postexercise (79). It was reported that there was a significant difference between HMB/KIC
and placebo groups for the percentage change in 1 repetition maximum in the biceps
curl (P ≤ 0.05) (79). Also, there was a significant difference in the CK response between
the groups, which increased over the 48h following exercise in the placebo group but, in
the HMB/KIC group CK levels showed very little increase after exercise (79). The
percentage increase in limb girth was attenuated in the HMB/KIC group over the 72h
post-exercise period and it returned to pre-exercise levels faster than the placebo group
(79). Finally, DOMS was significantly lower at 24h post-exercise in the HMB/KIC group
when compared to the placebo group (79). The authors concluded that HMB and KIC
supplementation attenuated muscle damage in non-resistance trained males following a
single bout of eccentric resistance exercise (79). Also, HMB/KIC had a significant effect
on the percentage decrement in muscle function demonstrated by a greater decrement
in 1 repetition maximum strength in the placebo group over the recovery period (79).
The attenuated CK response in the HMB/KIC group indicated that muscle damage was
reduced following the exercise protocol, perhaps via enhanced cell membrane integrity
(79).
Knitter et al. examined the effects of HMB supplementation on muscle damage
after a prolonged run (27). After 6 weeks of supplementation subjects completed a
20km run and plasma creatine phosphokinase (CPK) and lactate dehydrogenase (LDH)
activity were measured as markers of muscle damage (27). The HMB group
experienced a significantly lower CPK response (P = 0.05) and lower LDH levels (P =
0.003) compared with the placebo group over the 4 days after the prolonged run (27).
The authors concluded that because both groups performed equally well in the
prolonged run, the larger increases in enzyme activity in the placebo group suggest that
they sustained more muscle damage as a result of the run (27). These findings are
consistent with the hypothesis that HMB supplemented subjects experienced less
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muscle damage or that they recovered from muscle damage at a faster rate when
compared to a placebo group (27).
Another study that examined HMB supplementation during a resistance training
program was conducted by Nissen et al. (39). In this study three groups of subjects
weight lifted for 3 weeks and supplemented with either 0, 1.5, or 3g per day of HMB (39).
The authors reported that the increase in lower body weight lifted during the study was
greater in the HMB groups than in the unsupplemented group (P < 0.01) (39). The
unsupplemented subjects increased the number of abdominal efforts by 14% during the
3 weeks, whereas both HMB groups increased the number of abdominal efforts
approximately 50% over the 3 week study (P < 0.05) (39). Also, after one week of
exercise urinary methylhistidine (MH), a marker for muscle damage, increased 94% in
subjects not supplemented with HMB, 85% in subjects supplemented with 1.5g HMB,
and 50% in subjects supplemented with 3g HMB (39). In week two MH was 27% above
basal level in the control group, and 4 and 15% below the basal level for the 1.5 and 3g
HMB groups (39). During the third week of the study, HMB did not have a significant
effect on MH (39). The authors concluded that these changes suggest that HMB
prevents or slows muscle damage as well as partially preventing the increase in
proteolysis associated with intense muscular work (39).
The second group of research studies that have reported positive effects of HMB
supplementation are ones that have reported increases in strength and/or increases in
fat free mass (Table 2.2). The first of these studies was conducted by Pinheiro et al. and
evaluated the effects of HMB supplementation for 4 weeks upon metabolic parameters
and skeletal muscle contractile function in rats (57). It was reported that HMB
supplementation increased muscle tetanic force by 18.2% (P = 0.042) and increased the
resistance to acute fatigue in the gastrocnemius muscle (P < 0.05) (57). Since fatigue
has been associated with increased muscle damage induced by contractile activity, the
authors suggested that HMB supplementation decreased exercise induced muscle
damage, due to its increased resistance to acute fatigue (57). This protective effect of
HMB against contractile activity induced damage may be associated to increased
stability of muscle plasma membrane (57). The authors concluded that HMB
supplementation is associated with increased intrinsic force capacity of single skeletal
muscle fibers and prevention of acute muscle fatigue (57).
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Gallagher et al. employed an 8 week supplementation period with either 0, 3, or
6g of HMB per day during a resistance training program to determine whether a higher
dose of HMB provided any additional benefits (16). It was reported that HMB
supplementation elicited no differences in one repetition maximum strength compared
with the placebo group (17). But, the 3g per day HMB group improved isometric knee
extension torque by 32% which represented a greater improvement than the 0 and 6g
per day groups (P < 0.05) (16). The CK values taken at 48h after the initial exercise
bout were increased in the 0g per day group when compared to the other two groups (P
< 0.05) (16). Also, the 3g per day group demonstrated a greater increase in fat free
mass (1.9kg) from pre to post-training than the other two groups (P < 0.05) (16). The
authors concluded that HMB supplementation appears to increase peak isometric
torque, and fat free mass, and decrease plasma CK activity (16). Also, higher doses of
HMB (6g per day) do not promote greater strength or fat free mass gains (16).
Portal et al. assessed the effect of 7 weeks of HMB supplementation on elite
male and female junior volleyball players during the initial phase of the training season
(59). It was reported that HMB supplementation resulted in a significantly greater
increase of fat-free mass (P = 0.00), significantly greater decrease in percent body fat (P
= 0.04) and a significantly greater strength gain in 6 repetition maximum bench press (P
= 0.00) and leg press (P = 0.00) (59). HMB supplementation also resulted in a
significant greater increase in peak (P = 0.00) and mean (P = 0.00) anaerobic power
(59). The authors concluded that HMB supplementation was associated with a greater
increase in muscle mass, muscle strength, and anaerobic properties in elite male and
female adolescent volleyball players (59).
A study conducted by Thomson et al. determined the effects of nine weeks of
HMB supplementation during a resistance training program on the strength and body
composition of resistance trained males (76). It was reported that HMB supplementation
substantially increased leg extension strength (9.1 ± 7.5 kg, P = 0.05) but, the effect on
bench press (-1.9 ± 9.3kg, P = 0.72) and bicep preacher curl (-1.7 ± 4.7 kg, P = 0.51)
was unclear (76). Also, the overall combined lift strength was trivial (1.6 ± 4.3 kg, P =
0.52) (76). The increase in body mass (P = 0.35) and fat free mass (P = 0.84) were
negligible (76). The authors suggested that if HMB acts via accentuating cholesterol
synthesis and is used as a structural component of cell membranes, it may support
membrane function that is essential for excitation and optimal contractile performance
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during resistance exercise (76). The authors concluded that HMB supplementation in
conjunction with resistance training may result in meaningful improvements in lower
body strength and benefits to lean mass are unlikely, but small reductions in fat mass
are possible in resistance trained males (76).
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Table 2.2: Summary of Studies that Reported Positive Effects of HMB Supplementation
Authors

Subjects

Exercise Protocol

Ostaszewski
et al. (51)

Rat and
chicken whole
muscles

Panton et al.
(56)

Van
Someren et
al. (79)

43 Males and
41 females –
Trained and
untrained
groups
6 Nonresistance
trained males

None – Protein
synthesis and
breakdown were
measured
Resistance training – 4
weeks, 3 times per
week, 3 sets of 3-6
repetitions

Knitter et al.
(27)

Supplementation
Duration
Muscles
incubated in
HMB solution for
2 hours
4 Weeks

HMB Dosage

Outcome Measurements

Muscles
incubated in
1mM HMB
solution
3g per day

1) Protein synthesis
2) Protein breakdown

1) HMB inhibited proteolysis

1) Plasma creatine phosphokinase
2) Body composition
3) Strength tests – 1 Repetition maximum –
Bench press, leg press, leg extension

1) Both males and females respond to HMB
2) HMB response did not appear to be
dependent on previous training levels

1) Concentric 1 repetition maximum
2) Plasma creatine kinase activity
3) Muscle soreness (DOMS)
3) Limb girth
4) Range of Motion
1) Maximal oxygen consumption (Vo2 max)
2) Body composition
3) Plasma creatine phosphokinase
4) Lactate dehydrogenase

1) HMB and KIC attenuated muscle damage
2) HMB/KIC attenuated increase in creatine
kinase, DOMS, and limb girth

1) HMB groups increased abdominal
exercises and lower body weight lifted to a
greater degree
2) HMB groups had smaller methylhistidine
activity increases
1) HMB increased tetanic forces by 18.2%
2) HMB increased resistance to acute fatigue
in the gastrocnemius muscle
1) HMB elicited no differences in one
repetition maximum
2) 3g per day HMB group improved isometric
knee extension torque
3) 3g per day HMB group had a greater
increase in fat free mass
1) HMB was associated with a greater
increase in muscle mass, muscle strength,
and anaerobic properties

3 sets of 10 repetitions
of single arm eccentric
biceps curls at 70% 1
repetition maximum

14 Days

HMB - 3g per
day
KIC – 0.3g per
day

8 Males and 8
Females

20km prolonged run

6 Weeks

3g per day

Nissen et al.
(39)

41 Males

Resistance training – 3
days per week, 3 sets
of 3-5 repetitions

3 Weeks

1.5g or 3.0g
per day

1) Methylhistidine activity
2) Lactate dehydrogenase
3) Body Composition
4) Fat free mass

Pinheiro et
al. (57)

24 Male
Wistar rats

4 Weeks

320 mg/kg per
day

1) Muscle twitch force
2) Tetanic muscle force

Gallagher et
al. (16)

37 Untrained
males

None – Pre and post
supplementation
measures only
Resistance training – 3
sets of 10 repetitions
and a final set to
failure

8 Weeks

0, 3, or 6g per
day

Portal et al.
(59)

15 male and
14 female
elite junior
volleyball
players (13.5 –
18 years old)
22 Resistance
trained males

- Resistance training –
65-75% of one
repetition maximum
- Endurance training –
long distance running

7 Weeks

3g per day

Resistance training – 3
sessions per week, 2-3
sets, 5-15 repetitions

9 Weeks

3g per day

1) Maximal isometric contractions
2) Concentric and eccentric isokinetic
evaluation
3) Fatigue evaluation
4) Plasma creatine phosphokinase
5) Body composition
1) Body composition
2) Muscle strength – Upper and lower body
6 repetition maximum tests
3) Anaerobic power – 30s Wingate test
4) Aerobic power – 20 min shuttle run test
5) Hormones and inflammatory mediators
1) Strength – 1 repetition maximum – Bicep
curl, bench press, leg extension
2) Body composition

Thomson et
al. (76)

Findings
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1) HMB group showed lower levels of
creatine phosphokinase and lactate
dehydrogenase when compared to a placebo
group

1) HMB increased leg extension strength
2) Overall combined lift strength was trivial
3) Increase in body mass and fat-free mass
was negligible

Even though there cannot be any clear cut conclusions drawn from the current
research on HMB supplementation, there can be some general guidelines drawn. Most
of the studies used a dosage of 3g per day for HMB supplementation and it appears that
short term use and increased dosing are not useful (54, 73). Inconsistent gains in upper
vs. lower body strength have been observed with the majority of the improvements being
in lower body strength (66). Supplementation gains may also be related to the training
status of the subjects involved, with greater gains more likely seen in less trained
subjects (54). There is a pattern for reduction in markers of muscle damage with HMB
supplementation but, the magnitudes are variable (66). It is believed that HMB
supplementation exerts positive effects in conditions in which muscle proteolysis is more
pronounced, such as sedentary individuals and persons with AIDS or cancer (54, 91).
Also, the type of muscle contraction may play a role in the amount of gains that are seen
with HMB, with eccentric contractions seeing more gains, due to higher muscle tension
and greater muscle damage (91). There have been no adverse effects on hematology,
or hepatic or renal function with HMB supplementation and some studies reported a net
decrease in total cholesterol, low density lipoprotein cholesterol, and systolic blood
pressure (18, 43). Also, at this time HMB is currently not banned from any federal,
international, or other sporting organizations (54).
Conclusion
Peripheral physiological muscle fatigue is a problem that affects many other
people besides athletes and those partaking in exercise programs. Muscle fatigue can
affect those suffering from long term illnesses such as AIDS and cancer or even young,
middle, and older aged adults completing their activities of daily living. The mechanisms
of muscle fatigue are not know for sure but, most current research points to a defect in
E-C coupling as the main source of muscle fatigue. This E-C uncoupling is the main
cause of reduced muscle force and LFF which can last for several days. This LFF is
most often caused by eccentric muscle contractions which cause more muscle damage
than concentric or isometric contractions. Eccentric contractions affect everyone
everyday of their lives. Just walking on a level surface involves a great deal of eccentric
muscle contractions. If someone engages in an increase of eccentric contractions such
as increased walking, walking downhill, or a more structured exercise program it is very
likely they will experience increased muscle damage and increased LFF. If a nutritional
supplement can be used to reduce this muscle damage, caused by eccentric muscle
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contractions, then the decreased force production of LFF can be avoided. HMB
supplementation has been suggested and shown to reduce muscle damage during
activity. If supplementation with this substance can be shown to reduce LFF caused by
eccentric muscle contractions then it may provide quicker recovery from physical activity
for recreational athletes, the general public, and people suffering from long term
illnesses.
Some studies demonstrate that HMB has the ability to increase strength gains
and fat free mass gains during a resistance training program. It may accomplish this
through reducing the amount of muscle fatigue after one bout of physical activity,
allowing the muscle to perform more work in a repeated bout of activity, therefore
producing a greater training effect and greater gains in strength and fat free mass. But,
to date there have not been any studies determining HMB’s ability to reduce muscle
fatigue after a bout of physical activity. Also, there does seem to be reduced markers of
muscle damage with HMB supplementation (17, 40, 55, 80). So, HMB supplementation
may be effective in reducing LFF caused by muscle damage. To this date a research
study has not been found investigating the effects of HMB supplementation and the
reduction of LFF. Studies have shown that there are changes to rapid muscle force
characteristics after a bout of physical activity. But, there have not been any studies that
have tried to reduce these changes through nutritional supplements or any other means.
So, future research should be focused on HMB’s ability to reduce changes in rapid
muscle force characteristics and long term muscle fatigue.
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Chapter III: Methodology
Subjects
A total of 33 healthy recreationally active (physically active for 60 mins per day 35 days per week) young (18-35 yrs old) adults (15 women and 18 men) participated in
this study. After providing written informed consent approved by the University of
Kentucky Office of Research Integrity Medical Institutional Review Board, each subject
filled out a Physical Activity Readiness-Questionnaire and Health History Form to identify
any existing contraindications to the testing procedures as specified in the American
College of Sports Medicine Guidelines for Exercise Testing and Prescription (1).
Additional contraindications to inclusion in this study were previous lower limb orthopedic
injuries and/or limitations prohibiting completion of the muscle testing or fatiguing
protocols included in this investigation.
Testing Procedures
Prior to all pre and post supplementing muscle testing sessions, all subjects
completed a familiarization session. This was followed by scheduling and completion of
the anthropometric and body composition measurement testing, Pre-Supplement
baseline session with fatigue protocol, Pre-Supplement 48 hour recovery session, and
Pre-Supplement 96 hour recovery session. The Pre-Supplement measures were
performed on a randomly selected lower limb of each subject. Identical testing
procedures were then performed on the opposing lower limb following 3 wks of
supplementation. This supplementation consisted of a 1 gram tablets consumed 3 times
daily (morning, mid-day, and evening) of calcium β-Hydroxy-β-Methylbutyrate (HMB), for
a total of 3 grams per day. The Post-Supplement testing provided Post-Supplement
baseline session with fatigue protocol, Post-Supplement 48 hour recovery session, and
Post-Supplement 96 hour recovery session, thus allowing a repeated measures between
lower limb muscle testing study design. During each testing period maximal voluntary
isometric contraction (MVC), peak twitch torque, 10/50 Hz ratio stimulation, and EMG
measurements were taken. After the baseline with fatigue protocol session the subject
returned on two more occasions at approximately 48 and 96 hours after the fatigue
protocol to complete the recovery measurements. While participating in this study,
subjects were asked to maintain their current exercise and dietary patterns and to
abstain from other nutritional supplements and energy drink consumption. Twenty-four
hours prior to Pre and Post Supplement baseline sessions with fatigue protocol, subjects
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were asked to refrain from nonprescription drugs, exercise, alcohol, energy drink
consumption, and caffeine.
Anthropometric and Body Composition Measurements. Standing height and body
weight were determined for each subject using a wall-fixed stadiometer (Seca
Statiometer Pat. No. 4694581) and a calibrated scale (Teraoka D1-10; Singapore),
respectively. A total body dual energy x-ray absorptiometry (DXA) scan was performed
on each subject using a Lunar Prodigy (Lunar Inc., Madison, WI) densitometer to
determine relative adiposity (%Fat). All scans were analyzed by a single trained
investigator using Lunar software version 14.10. In addition, range of motion
measurements of the ankle were taken using a transparent plastic goniometer (Baseline,
Diagnostic and Measuring Instruments, White Plains, NY) immediately prior to the
muscle testing performed on Pre-and Post-Supplement baseline sessions, 48 hour
recovery sessions, and 96 hour recovery sessions.
Pre and Post Supplement Baseline Session with Fatigue Protocol
Each baseline session with fatigue protocol was preceded by a 5 min lowintensity warm-up performed on a recumbent cycle ergometer. This was followed by
baseline isometric skeletal muscle strength (MVC) and skeletal muscle activation
measures (EMG). Electromyography was used simultaneously throughout the skeletal
muscle measures. Following the Pre and Post Supplement baseline measures, a
muscle fatigue protocol was implemented followed by identical isometric skeletal muscle
strength, skeletal muscle activation and EMG measures. This process of imposing a
muscle fatiguing protocol followed by skeletal muscle strength, activation and EMG
measures was repeated a total of 4 times (4 sets of 25 repetitions) with 15 seconds rest
between fatiguing and measurement sets. To complete Pre and Post Supplement
baseline session with fatigue protocol, muscle strength, muscle activation and EMG
measures were again taken at 2, 5, 10, 15, and 20 mins following the final fatiguing bout
to determine the acute recovery measures.
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Figure 3.1: Study Overview

Figure 3.2: Pre and Post- Supplement Baseline and Fatigue Protocol Session Overview

Isometric Skeletal Muscle Strength
Isometric strength of the tibialis anterior was obtained from the Biodex Multi-Joint
System 4 isokinetic dynamometer (Biodex Medical Systems, Shirley, NY) with the
Biodex Advantage software version 4.0. All isometric tests were administered by a single
trained investigator. Participants sat in a slightly reclined position with the hip, knee, and
ankle angles set at 100, 140, and 30 degrees plantar flexion. The participants were
stabilized with 2 shoulder straps, a waist strap, and a thigh strap. All voluntary and
evoked isometric contractions were performed at an ankle joint angle of 30 degrees of
plantar flexion. Before testing, familiarization with the equipment and testing procedures
were completed by having the participant perform three submaximal contractions on
each strength test. For the test procedures, each participant was asked to complete
three nonconsecutive maximal isometric contractions (ankle joint angle of 30 degrees
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plantar flexion). There were 120 seconds rest between each maximal isometric
contraction. Each participant was instructed to exert maximal voluntary effort by
contracting as hard and as fast as possible during the isometric contractions. The
highest contraction amplitude value of the three attempts for each exercise was
recorded and used in the subsequent analyses.
Electromyography
To monitor changes in muscle electrical activity during isometric strength testing
and the development of fatigue, electromyographic signals were collected. Prior to
electrode placement, the skin was shaved of any hair and cleaned with pre-soaked
alcohol swabs. Surface electrodes (Delsys system Bagnoli DE-2.1 single differential
electrodes, inter-electrode distance 10 mm, bandwidth 20-450 Hz, Natick, MA) were
placed on the tibialis anterior ( ~ 7 cm distal to the tibial tuberosity and ~ 2 cm lateral to
the tibial anterior border) and soleus muscles ( ~ 2 cm distal to the medial head of the
gastrocnemius). Data was collected using the Delsys Bagnoli 8-channel digital interface
(Model number: DS-B03, Natick, MA). The gain setting was 1000 Hz and the sampling
rate was 1000 Hz. The ground electrode was place on the patella of the limb that was
not being tested. At the peak of each MVC the root mean squared value was recorded
for one second. In addition, all raw EMG data was smoothed with a fourth order
Butterworth filter.
Skeletal Muscle Activation
Stimulated contractions of the dorsiflexors were evoked electrically with two
round carbon rubber electrodes (3 cm diameter; Medi-Stim, Wabasha, Minnesota, USA),
positioned at the optimal site for twitch torque. The anode was positioned anterior, and
the cathode 2-3 cm inferior to the tibial tuberosity over the deep branch of the common
fibular nerve. A computer-triggered stimulator (model DS7AH, Digitimer, WelwynGarden
City, Hertfordshire, UK) set at 400V provided the electrical stimulation using a pulse
width of 100 ms.
Peak twitch torque was determined by increasing the current until a plateau in
dorsiflexor peak torque was reached and then the current was further increased by at
least 15% to ensure supramaximal stimulation was achieved. This stimulation intensity
was used to evoke a twitch (on pulse) and a doublet (two pulses at a 10 ms interpulse
interval) to assess potentiation and voluntary activation, respectively. Peak 50Hz torque
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was determined by increasing the current until a plateau in dorsiflexor peak torque was
achieved. Prolonged low-frequency force depression was accessed via the 10Hz (5
pulses over 0.5s) and 50Hz stimulus (25 pulses over 0.5s) peak torque ratio.

Fatigue Protocol
All voluntary and evoked isometric dorsiflexion contractions were performed at an
ankle joint angle of 300 plantarflexion (PF) (21). Eccentric or lengthening contractions
began at the neutral ankle angle (00 PF) and continued until 30 degrees of plantarflexion.
The fatigue protocol consisted of 4 sets of 25 eccentric isokinetic dorsiflexion
contractions at 300/s through a 30 degree range of motion with each set separated by ~
30 s of rest (21). Dominate or non-dominate lower limb was randomized. During this
fatigue protocol EMG measurements were recorded. Immediately after the last set, the
post fatigue measurements were taken and consist of: MVC peak torque,peak twitch
torque, and 10/50 Hz ratio stimulation. These measurements were taken again during
the recovery period at: 2, 5, 10, 15, and 20 minutes after the fatigue protocol.
Supplementation
ON™ HMB is a commercially available nutritional supplement for adult use only.
Participants consumed one tablet three times per day (morning, mid-day, and evening)
containing a total of 3000 mg of calcium β-Hydroxy-β-Methylbutyrate
Statistical Analysis
Mean differences between groups were examined by using a repeated measures
ANOVA and the level of significance was set at P < 0.05. When significant differences
were observed a post hoc analysis using a Bonferroni correction was used to determine
where significant differences existed. All data analyses were completed using SAS 9.3.
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Chapter IV: Results
A total of 33 subjects enrolled in this study (15 Females, 18 males). Of the 15
female subjects enrolled, 12 completed all testing procedures and 3 failed to complete
the post-supplement measures due to lack of compliance. Of the 18 male subjects
enrolled, 14 completed all testing procedures and 4 failed to complete the final postsupplement (96-hours recovery) visit due to temporary testing equipment mechanical
failure or illness. Subject characteristics are shown in Table 4.1.
Table 4.1: Subject Characteristic Measurements
Mean (SD)

Range

Age (Years)

23.2 ± 4.3

18 – 34

Height (cm)

173.1 ± 18.3

155.0 – 188.0

Weight (kg)

76.1 ± 15.8

52.9 – 126.5

BMI

25.2 ± 4.1

20.0 – 36.4

Body Fat (%)

22.5 ± 9.5

5.6 – 39.8

There were significant measurement differences for the MVC torque, 10 Hz Peak
Torque, 50 Hz Peak Torque, 10/50 Hz Torque Ratio, and TA EMG variable measures.
The results of these measurement differences are summarized below. However, there
were no other variables that showed significant differences between pre-supplement and
post-supplement measures, or over any of the measurement times.
10/50 Hz Torque Ratio
There was a significant difference in the 10/50 Hz torque ratio over time
(p<0.0001) and between the pre-supplement limb and the post-supplement limb
(p=0.005; Table 4.2). There was no significant difference between limb 10/50 Hz torque
ratios during the fatigue protocol or the 20-minute recovery period (p=0.16) but, there
was a significant difference at the 48-hour and 96-hour recovery measurement times
(p=0.005).
The baseline 10/50 Hz torque ratio for the pre-supplement limb was 0.51 ± 0.14
and for the post-supplement limb it was 0.49 ± 0.11 (Table 4.2). At the end of the fourth
set of the fatigue protocol it was reduced to 63% of baseline for the pre-supplement limb
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(p<0.0001) and 67% of baseline for the post-supplement limb (p<0.0001; Table 4.2).
Therefore, after the fatigue protocol, both the pre-supplement limb and the postsupplement limb had a significant relative 10/50 Hz torque ratio deficit. During the
recovery period the 10/50 Hz torque ratio continued to decrease at a greater rate in both
limbs. At the 20-minute recovery measurement time it was reduced to 49% of baseline
in the pre-supplement limb (p<0.0001) and 57% of baseline in the post-supplement limb
(p<0.0001; Table 4.2). Therefore, after 20 minutes of recovery both the pre-supplement
limb and the post-supplement limb had a significant relative 10/50 Hz torque ratio deficit.
At the 48-hour recovery measurement time, the 10/50 Hz torque ratio in the presupplement limb was 0.40 ± 0.12 and for the post-supplement limb it was 0.47 ± 0.11
(Table 4.2). At this measurement time the 10/50 Hz torque ratio, in the pre-supplement
limb, was reduced to 78% of baseline (p<0.0001) and the post-supplement limb was
reduced to 96% of baseline (p=0.38; Table 4.2). Therefore, after 48 hours of recovery,
the pre-supplement limb had a significant relative 10/50 Hz torque ratio deficit and the
post-supplement limb had no significant relative 10/50 Hz torque ratio deficits.
The 10/50 Hz torque ratio in the pre-supplement limb at the 96-hour recovery
measurement time was 0.44 ± 0.14 and for the post-supplement limb it was 0.46 ± 0.12
(Table 4.2). At this measurement time the 10/50 Hz torque ratio, in the pre-supplement
limb, was reduced to 86% of baseline (p=0.02) and in the post-supplement limb it was
94% of baseline (p=0.31; Table 4.2). Therefore, after 96 hours of recovery, the presupplement limb had a significant relative 10/50 Hz torque ratio deficit and the postsupplement limb had no significant relative 10/50 Hz torque ratio deficits.
10 Hz Peak Torque
There was a significant difference in 10 Hz peak torque over time (p<0.0001) and
between the pre-supplement limb and the post-supplement limb (p=0.0008; Table 4.2).
There was no significant difference between limbs during the fatigue protocol or the 20minute recovery period (p=0.89; Table 4.2). However, there was a significant difference
at the 48-hour and 96-hour recovery measurement times (p=0.0008; Table 4.2).
The baseline 10 Hz peak torque for the pre-supplement limb was 4.8 ± 2.2 Nm
and for the post-supplement limb it was 4.7 ± 2.4 Nm (Table 4.2). At the end of the
fourth set of the fatigue protocol the 10 Hz torque was reduced to 56% of baseline in the
pre-supplement limb (p<0.0001) and in the post-supplement limb it was reduced to 56%
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of baseline (p<0.0001; Table 4.2). Therefore, after the fatigue protocol, both the presupplement limb and the post-supplement limb had a significant relative 10 Hz peak
torque deficit. The reduction in the 10 Hz peak torque continued throughout the
recovery period, and at the 20-minute recovery measurement time it was 47% of
baseline for the pre-supplement limb (p<0.0001) and 44% of baseline for the postsupplement limb (p<0.0001; Table 4.2). Therefore, after 20-minutes of recovery, both
the pre-supplement limb and the post-supplement limb still had a significant relative 10
Hz peak torque deficit.
The 10 Hz peak torque in the pre-supplement limb at the 48-hour recovery
measurement time was 3.7 ± 2.1 Nm and for the post-supplement limb it was 4.4 ± 1.9
Nm (Table 4.2). At the 48-hour recovery measurement time, in the pre-supplement limb,
the 10 Hz torque was reduced to 77% of baseline (p<0.0001) and the post-supplement
limb was reduced to 94% of baseline (p=0.26; Table 4.2). Therefore, after 48 hours of
recovery, the pre-supplement limb had a significant relative 10 Hz peak torque deficit
and the post-supplement limb had no significant relative 10 Hz peak torque deficits.
The 10 Hz peak torque in the pre-supplement limb at the 96-hour recovery
measurement time was 4.2 ± 2.4 Nm and for the post-supplement limb it was 4.3 ± 2.2
Nm (Table 4.2). At the 96-hour recovery measurement time the 10 Hz torque in the presupplement limb was reduced to 88% of baseline (p=0.05), and for the post-supplement
limb it was 94% of baseline (p=0.53; Table 4.2). In addition, there was a significant
increase in 10 Hz peak torque from the 48-hour recovery measurement time to the 96hour recovery measurement time in the pre-supplement limb (p=0.02;Table 4.2).
Therefore, after 96 hours of recovery, the pre-supplement limb had a significant relative
10 Hz peak torque deficit and the post-supplement limb had no significant relative 10 Hz
peak torque deficits.
50 Hz Peak Torque
There was a significant difference in 50 Hz peak torque over time during the
fatigue protocol and the 20-minute recovery period (p<0.0001). But, there was no
significant difference between baseline and the 48-hour and 96-hour recovery
measurement times (p=0.19). Similarly, there was no significant difference in the 50 Hz
peak torque between the pre-supplement and post-supplement limbs during the fatigue
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protocol and 20-minute recovery period (p=0.80) or between the 48-hour and 96-hour
recovery measurement times (p=0.25; Table 4.2).
The baseline 50 Hz peak torque for the pre-supplement limb was 10.1 ± 5.5 Nm
and for the post-supplement limb it was 9.8 ± 5.0 Nm (Table 4.2). At the end of the
fourth set of the fatigue protocol the 50 Hz peak torque was reduced to 84% of baseline
in the pre-supplement limb (p<0.0001) and 80% of baseline in the post-supplement limb
(p=0.02; Table 4.2). Therefore, after the fatigue protocol, both the pre-supplement limb
and the post-supplement limb had a significant relative 50 Hz peak torque deficit. During
the recovery period the 50 Hz peak torque continued to increase and at the 20-minute
recovery measurement time it was recovered to 91% of baseline in the pre-supplement
limb (p=0.07) and 86% of baseline in the post-supplement limb (p=0.02; Table 4.2).
Therefore, after 20 minutes of recovery the pre-supplement limb did not show significant
relative 50 Hz peak torque deficits and the post-supplement limb had a significant
relative 50 Hz torque deficit.
There were no significant differences in the 50 Hz peak torque at the 48-hour
recovery measurement time or the 96-hour recovery measurement time for either the
pre-supplement limb (p= 0.18) or the post-supplement limb (p=0.25).
MVC Torque
To test the reliability of the MVC torque measurement an interclass correlation
coefficient (ICC) and method error was calculated between the familiarization and presupplement testing sessions. The ICC for MVC torque was 0.999 and the method error
was 0.51 Nm. There was a significant difference in MVC torque over time (p<.0001) and
between the pre-supplement limb and the post-supplement limb (p<.0001; Table 4.2).
There was no significant difference between limbs during the fatigue protocol or the 20minute recovery measurement time (p=.48) however, there was a significant difference
at the 48-hour and 96-hour recovery measurement times (p<.0001).
At baseline the MVC torque for the pre-supplement limb was significantly higher
when compared to the post-supplement limb (p=0.001). The MVC torque for the presupplement limb at baseline was 27.6 ± 11.7 Nm and for the post-supplement limb it was
21.9 ± 8.5 Nm (Table 2). After the fourth set of the fatigue protocol in the presupplement limb MVC torque was reduced by 13.5 Nm resulting in 51% of the baseline
measures (p<.0001). The post-supplement limb was reduced by 10.6 Nm resulting in
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52% of baseline measures after the fourth set of the fatigue protocol (p<.0001; Table
4.2). Therefore, after the fatigue protocol, both the pre-supplement and post-supplement
limbs had a significant relative MVC torque deficit. After 20-minutes of recovery
following the final set of the fatigue protocol, the MVC torque in the pre-supplement limb
returned to 17.5 ± 1.5 Nm. At the same measurement time the post-supplement limb
returned to 15.7 ± 1.6 Nm. These values were 65% of baseline for the pre-supplement
limb and 75% of baseline for the post-supplement limb. The MVC torque for both the
pre-supplement limb (p<.0001) and post-supplement limb (p=.003) was still significantly
reduced from baseline following the 20-minute recovery time (Table 4.2). Therefore,
after 20-minutes of recovery, both the pre-supplement and post-supplement limbs had a
significant relative MVC torque deficit.
The MVC torque in the pre-supplement limb at the 48-hour recovery
measurement time was 22.3 ± 9.8 Nm resulting in 81% of the baseline measures
(p<.0001; Table 4.2). The MVC torque for the post-supplement limb at this same
measurement time was 20.5 ± 9.5 Nm resulting in 94% of the baseline measures (p=.53;
Table 4.2). Therefore, after 48-hours of recovery, the pre-supplement limb had a
significant relative MVC torque deficit and the post-supplement limb had no significant
relative MVC torque deficits.
The MVC torque in the pre-supplement limb at the 96-hour recovery
measurement time was 22.3 ± 10.2 Nm resulting in 81% of the baseline measures
(p<0.0001; Table 4.2). The MVC torque for the post-supplement limb at this same
measurement time was 21.3 ± 9.4 Nm resulting in 97% of the baseline measures
(p=0.76; Table 4.2). Therefore, after 96 hours of recovery, the pre-supplement limb had
a significant relative MVC torque deficit and the post-supplement limb had no significant
relative MVC torque deficits.
TA EMG
There was a significant difference in TA EMG over time (p<.0001) but, there was
no significant difference between the pre-supplement and post-supplement limbs
(p=0.08; Table 4.2). Also, at baseline the TA EMG in the pre-supplement limb was
significantly higher than the post-supplement limb (p=0.04).
The baseline TA EMG for the pre-supplement limb was 161.3 ± 62.9 µV and for
the post-supplement limb it was 141.1 ± 49.5 µV (Table 4.2). At the end of the fourth set
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of the fatigue protocol it was reduced to 64% of baseline for the pre-supplement limb
(p<0.0001) and 77% of baseline in the post-supplement limb (p<0.0001; Table 4.2).
Therefore, after the fatigue protocol, both the pre-supplement limb and the postsupplement limb had a significant relative TA EMG deficit. During the recovery period
the TA EMG steadily increased and at the 20-minute recovery measurement time the TA
EMG was recovered to 71% of baseline in the pre-supplement limb (p=0.0002) and 81%
of baseline in the post-supplement limb (p=0.003; Table 4.2). Therefore, after 20
minutes of recovery, both the pre-supplement limb and the post-supplement limb had a
significant relative TA EMG deficit.
The TA EMG in the pre-supplement limb at the 48-hour recovery measurement
time was 139.8 ± 64.1 µV and for the post-supplement limb it was 134.5 ± 41.9 µV
(Table 4.2). At the 48-hour recovery measurement time the TA EMG was reduced to
86% of baseline (p=0.01) in the pre-supplement limb and 96% of baseline in the postsupplement limb (p=0.064; Table 4.2). Therefore, after 48 hours of recovery, the presupplement limb had a significant relative TA EMG deficit and the post-supplement limb
had no significant relative TA EMG deficits.
The TA EMG in the pre-supplement limb at the 96-hour recovery measurement
time was 139.3 ± 56.1 µV and for the post-supplement limb it was 135.2 ± 47.3 µV
(Table 4.2). At the 96-hour recovery measurement time the TA EMG was reduced to
86% of baseline (p=0.01) in the pre-supplement limb and 98% of baseline in the postsupplement limb (p=0.64; Table 4.2). Therefore, after 96 hours of recovery, the presupplement limb had a significant relative TA EMG deficit and the post-supplement limb
had no significant relative TA EMG deficits.
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Table 4.2: Pre-Supplement and Post-Supplement Measures for Fatigue Protocol and Recovery Period
Baseline

MVC Torque (Nm)
Pre-Supplement
Post-Supplement

Eccentric
Eccentric
Fatigue Set 1 Fatigue Set 2

Eccentric
Fatigue Set 3

Eccentric
Fatigue Set 4

27.6 ± 11.7
21.9 ± 8.5

23.8 ± 12.4
17.4 ± 7.5†

19.1 ± 11.9†
14.7 ± 8.2†

16.2 ± 9.9**
13.4 ± 7.3†

14.0 ± 9.1†
11.3 ± 6.8†

10 Hz Peak Torque (Nm)
Pre-Supplement
Post-Supplement

4.8 ± 2.2
4.7 ± 2.4

4.7 ± 2.3
4.6 ± 2.5

3.7 ± 2.2†
3.6 ± 2.4†

3.2 ± 2.0†
3.1 ± 2.2†

2.7 ± 1.9†
2.6 ± 1.8†

50 Hz Peak Torque (Nm)
Pre-Supplement
Post-Supplement

10.1 ± 5.5
9.8 ± 5.0

9.6 ± 4.8*
9.0 ± 4.4*

9.0 ± 4.5†
8.7 ± 4.7*

8.5 ± 4.5†
8.2 ± 4.5†

8.5 ± 4.6†
7.8 ± 4.4†

10/50 Hz Torque Ratio
Pre-Supplement
Post-Supplement

0.51 ± 0.14
0.49 ± 0.11

0.52 ± 0.16
0.51 ± 0.12

0.42 ± 0.16*
0.41 ± 0.13†

0.39 ± 0.16†
0.37 ± 0.14†

0.32 ± 0.15†
0.33 ± 0.12†

128.6 ± 62.2†
114.2 ± 43.8*

110.5 ± 41.6†
114.2 ± 43.8*

102.4 ± 42.2†
109.2 ± 47.1†

TA EMG (µ Volts)
Pre-Supplement 161.3 ± 62.9 139.2 ± 67.6*
Post-Supplement 141.1 ± 49.5 119.9 ± 46.3*

Numbers represent Mean ± Standard Deviation
MVC: Maximal Voluntary Contraction
TA EMG: Tibialis Anterior Electromyography
* p<0.05 Compared to Baseline, † p<0.0001 Compared to Baseline
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Table 4.2 (Continued): Pre-Supplement and Post-Supplement Measures for Fatigue Protocol and Recovery Period
Recovery 2 min

Recovery 5
min

Recovery 10
min

Recovery 15
min

Recovery 20
min

48 Hour
Recovery

96 Hour
Recovery

MVC Torque (Nm)
Pre-Supplement
Post-Supplement

15.6 ± 9.5†
14.0 ± 9.5†

17.4 ± 10.3†
15.3 ± 9.5*

17.8 ± 9.1†
15.8 ± 8.5*

17.8 ± 9.3†
15.3 ± 7.8*

17.9 ± 7.7†
16.4 ± 7.8*

22.3 ± 9.8†
20.5 ± 9.5

22.3 ± 10.2†
21.3 ± 9.4

10 Hz Peak Torque
(Nm)
Pre-Supplement
Post-Supplement

2.8 ± 1.8†
2.5 ± 1.7†

2.5 ± 1.8†
2.4 ± 1.7†

2.2 ± 1.4†
2.1 ± 1.3†

2.2 ± 1.5†
2.2 ± 1.3†

2.3 ± 1.5†
2.2 ± 1.2†

3.7 ± 2.1†
4.4 ± 1.9

4.2 ±2.4*
4.3 ± 2.2

50 Hz Peak Torque
(Nm)
Pre-Supplement
Post-Supplement

8.9 ± 4.9*
8.1 ± 4.9*

8.6 ± 5.2*
8.1 ± 4.9*

8.9 ± 5.2*
8.2 ± 5.1*

9.1 ± 5.0*
8.3 ± 5.0*

9.2 ± 5.0*
8.4 ± 4.7*

9.4 ± 4.7
9.7 ± 4.6

9.9 ± 5.3
9.8 ± 4.9

10/50 Hz Torque
Ratio
Pre-Supplement
Post-Supplement

0.33 ± 0.15†
0.32 ± 0.12†

0.29 ± 0.12†
0.30 ± 0.12†

0.27 ± 0.11†
0.28 ± 0.12†

0.25 ± 0.11†
0.28 ± 0.11†

0.25 ± 0.11†
0.28 ± 0.12†

0.40 ± 0.12†
0.47 ± 0.11

0.44 ± 0.14*
0.46 ± 0.12

TA EMG (µ Volts)
Pre-Supplement
Post-Supplement

99.0 ± 49.3†
99.0 ± 39.7†

107.6 ± 53.9†
105.1 ± 41.0†

111.1 ± 51.7†
107.3 ± 40.0†

112.5 ± 57.8†
111.9 ± 44.8*

115.2 ± 52.0*
114.2 ± 45.4*

139.8 ± 64.1*
134.5 ± 41.9

139.3 ± 56.1*
135.2 ± 47.3

Numbers represent Mean ± Standard Deviation
MVC: Maximal Voluntary Contraction
TA EMG: Tibialis Anterior Electromyography
* p<0.05 Compared to Baseline, † p<0.0001 Compared to Baseline
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Figure 4.1: MVC Torque Measurements for Pre and Post-Supplement Limbs

* p<.05 Compared to baseline

+ p<.0001 Compared to baseline

Figure 4.2: 10 Hz Peak Torque Measurements for Pre and Post-Supplement Limbs

* p<.05 Compared to baseline

+ p<.0001 Compared to baseline
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Figure 4.3: 50 Hz Peak Torque Measurements for Pre and Post-Supplement Limbs

* p<.05 Compared to baseline

+ p<.0001 Compared to baseline

Figure 4.4: 10/50 Hz Torque Ratio for Pre and Post-Supplement Limbs

* p<.05 Compared to baseline

+ p<.0001 Compared to baseline
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Figure 4.5: TA EMG for Pre and Post-Supplement Limbs

* p<.05 Compared to baseline

+ p<.0001 Compared to baseline
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Chapter V: Discussion
The primary purpose of this study was to determine if three weeks of HMB
supplementation could attenuate the effects of LFF caused by eccentric muscle
contractions of the TA muscle. The major finding of this study was that HMB did
attenuate the effects of LFF caused by eccentric muscle contractions in the TA muscle.
This positive finding was due to the results that demonstrated that the 10/50 Hz torque
ratio, and 10 Hz peak torque in the HMB post-supplement limb recovered faster when
compared to the pre-supplement limb. In addition, it was observed that the MVC torque
in the post-supplement limb recovered faster when compared to the pre-supplement
limb.
The 10/50 Hz torque ratio is a measure of LFF, and any significant reduction in
the 10/50 Hz torque ratio following completion of a fatigue protocol, is interpreted as LFF
(60). After the fatigue protocol, both the pre-supplement limb and the post-supplement
limb had a significant relative 10/50 Hz torque ratio deficit (Figure 4.4). This reduction in
the 10/50 Hz torque ratio indicated that the fatigue protocol used in this study, produced
significant LFF. Also, the amount of change in the 10/50 Hz torque ratio that was
observed in this study for the pre-supplement limb was similar to that found by Power et
al. (60).
The 10/50 Hz torque ratio for the post-supplement limb recovered faster when
compared to the pre-supplement limb (Figure 4.4). The post-supplement limb was
recovered at the 48-hour recovery measurement time and the pre-supplement limb had
not recovered at the 96-hour recovery measurement time. The current study supports
the findings of Jones and colleagues (1989) which reported a torque ratio reduction for
four days after an eccentric fatigue protocol (22). Jones et al. (1989) also reported that
the torque ratio did not return to baseline levels until seven days after the eccentric
fatigue protocol and that isometric and concentric contractions did not produce a
reduced torque ratio (22). Power et al. (2010) reported a depressed torque ratio was
present immediately after an eccentric fatigue protocol and was still present after 30
minutes of recovery (60). Since eccentric contractions have been reported to cause LFF
and is slow to recover, it is possible that this is a consequence of some form of damage
caused by the generation of high forces within the muscle (22). Based on the 10/50 Hz
torque ratio, the pre-supplement limb was still showing significant LFF at the 96-hour
recovery measurement time. In contrast, the post-supplement limb recovered faster,
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and at the 48-hour recovery measurement time it was no longer showing significant
signs of LFF. This is evidence that HMB supplementation positively affected the time
course of LFF after the fatigue protocol. This positive affect from HMB supplementation
may have been the result of reduced muscle damage in the post-supplement limb during
the fatigue protocol or an increased recovery rate following the fatigue protocol. Since
the current study did not employ any direct measure of muscle damage, it cannot be
concluded which possible mechanism of action of HMB supplementation, may have
occurred.
It has been suggested that HMB supplementation prevents muscle damage or
regenerates damaged muscle cell membranes after activity (26, 43, 46, 53, 66, 88). The
current study may be evidence that supports HMB’s ability to regenerate damaged
muscle cell membranes. This is based on the faster recovery of the 10/50 Hz torque
ratio and 10 Hz peak torque that was seen in the post-supplement limb in the current
study. This faster regeneration of damaged muscle cell membranes has been
suggested to be achieved by two mechanisms (26, 40, 50). The first mechanism
involves conversion of HMB, in the cytosol of the liver, to β-hydroxy-β-methylglutarateCoA (HMG-CoA) (26, 40, 50). HMG-CoA is then employed in cholesterol synthesis and
could be rate limiting when cholesterol synthesis is in high demand, such as during
periods of rapid cell growth or membrane repair that is seen after eccentric exercise
(17). In addition, stressed or damaged muscle cells may not be able to make sufficient
HMG-CoA to support adequate cholesterol synthesis for cell functions (41).
Supplemental HMB therefore, may be a source of HMG-CoA in damaged muscle cells to
maintain adequate cholesterol synthesis and plasma membrane function (41). The
second suggested mechanism contributing to the positive effects of HMB
supplementation concerns HMB’s ability to be polymerized and covalently bonded with
cell membrane structures to enhance membrane integrity (49, 50). This increased
integrity may also be accomplished through the additional source of cholesterol provided
by HMB supplementation (46). It has been hypothesized that the de novo synthesized
cholesterol is used to support the cell membrane integrity, and thus assist in the
prevention of muscle damage or used to regenerate damaged muscle cell membranes
(26). Therefore, HMB supplementation may provide the necessary amount of HMG-CoA
for cholesterol synthesis and membrane protection that would then result in decreased
muscle damage and quicker recovery from resistance exercise (17). This is supported
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by studies that have demonstrated that HMB supplementation has decreased markers of
muscle damage following strenuous exercise (17, 26, 40, 55).
The 10 Hz peak torque represents low frequency muscle stimulation and in the
current study it was used as another indicator of LFF. After the fatigue protocol, and
following the 20-minute recovery period, both the pre-supplement limb and the postsupplement limb had a significant relative 10 Hz peak torque deficit (Figure 4.2). This
supports the notion that LFF does not have a metabolic or ionic component. If a
metabolic or ionic waste product accumulation contributed to the LFF, an increase in the
10 Hz peak torque toward baseline would be expected during the recovery period as
seen in high frequency stimulation (i.e. 50 Hz) (32).
In the current study, based on the peak 10 Hz torque, there was still significant
LFF observed in the pre-supplement limb 96 hours after the fatigue protocol (Figure 4.2).
In contrast, the 10 Hz peak torque was recovered to non-significant levels in the postsupplement limb at 48 hours after the fatigue protocol. This is more evidence that HMB
supplementation reduced the recovery time of LFF in the current study. This is because
the recovery of the post-supplement limb at the 48-hour recovery measurement time is
in contrast to the pre-supplement limb and other findings reported (22). Jones et al.
(1989) reported that low frequency torque was reduced for the first four days after
eccentric exercise, and did not recover until seven days after eccentric exercise (22).
The primary characteristic of LFF is the reduction of muscle force at low
frequency stimulation (25). Motor unit discharge rates during voluntary skeletal muscle
activation rarely exceed 30 Hz, so any voluntary muscle contraction would be greatly
affected by LFF (25). This would include any strenuous activity, walking, stair climbing,
and all other activities of daily living (25). This effect of LFF on voluntary muscle
contraction could result in higher activation of the central nervous system, require the
recruitment of a larger number of motor units or increased firing frequency, and cause
greater feelings of effort during repetitive activities and may limit performance (25). The
current study found that three weeks of HMB supplementation significantly reduced the
slow recovery of LFF.
The 50 Hz peak torque represents high frequency muscle stimulation and in this
study it was used as an indicator of high frequency fatigue. At the end of the fatigue
protocol, both the pre-supplement limb and the post-supplement limb had a significant
relative 50 Hz peak torque deficit (Figure 4.3). During the 20-minute recovery period the
50 Hz peak torque increased in both limbs. This recovery in the 50 Hz peak torque
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indicated that high frequency fatigue recovered quickly and suggests that it has a
metabolic or ionic basis. It has been previously reported that, the buildup of metabolic
byproducts or ions from a fatigue protocol return toward resting levels during the early
stages of the recovery period (32). As these byproducts are restored toward resting
levels, the 50 Hz peak torque returns toward baseline levels (32). By the 48-hour
recovery measurement time the 50 Hz peak torque had recovered to non-significant
levels in both limbs. This is evidence that high frequency fatigue recovers faster than
LFF. There were no differences between the pre-supplement and post-supplement
limbs in the 50 Hz peak torque measurement during the fatigue protocol, or any recovery
measurement times. Therefore, based on the 50 Hz peak torque measurement it is
concluded that HMB supplementation had no effect on high frequency fatigue in the
current study.
After the fatigue protocol the MVC torque was reduced by 50% in both the presupplement and the post-supplement limbs and both the pre-supplement and postsupplement limbs had a significant relative MVC torque deficit (Figure 4.1). This amount
of reduction of force demonstrates that the fatigue protocol used in this study was
intense enough to produce a sufficient amount of muscle fatigue. This study utilized a
fatigue protocol adopted from Power et al. (2010) and achieved a greater degree of MVC
torque reduction (60). The subjects in the Power et al. study had a MVC torque
reduction to 72% of baseline after their fatigue protocol (60).
At the 20-minute recovery measurement time both the pre-supplement and postsupplement limbs had a significant relative MVC torque deficit (Figure 4.1). Due to the
short time period of this fatigue, it is theorized that the cause of this fatigue is the buildup
of some metabolite during the fatigue protocol. It has been reported that the
concentration of inorganic phosphate (Pi) increases in the muscle fiber during muscle
contractions (2). An increase in Pi in the muscle fiber reduces Ca2+ release and
therefore reduces cross bridge cycling and force production (2). This type of fatigue can
also be caused by a reduction in Ca2+ sensitivity (32). Reduced Ca2+ sensitivity is a
condition where force at a given free Ca2+ concentration is lowered and it would take
more Ca2+ release for the same amount of force production. (32). The accumulation of
Pi is also thought to reduce Ca2+ sensitivity in a fatiguing muscle (2). Since both the presupplement and post-supplement limbs were still significantly different from baseline,
after 20 minutes of recovery, it is concluded that HMB supplementation had no effect on
short term fatigue.
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Muscle damage caused by eccentric muscle contractions has been documented
directly by muscle biopsy samples and indirectly from losses in strength and range of
motion, increases in muscle soreness, and increases in blood muscle proteins, such as
creatine kinase (CK) and lactate dehydrogenase (LDH) (63). Among these markers,
change in force generating capacity is considered to be the most reliable (30). The MVC
torque in the post-supplement limb also recovered faster than the pre-supplement limb
at the 48-hour and 96-hour recovery measurement times (Figure 4.1). This is an
indicator that a degree of muscle damage was still present in the pre-supplement limb at
the 96-hour recovery measurement time. Since the post-supplement limb’s MVC torque
was nearly fully recovered after 48-hours of recovery, this study suggests that there was
a positive effect of HMB supplementation on muscle damage recovery time after the
fatigue protocol. Since both limbs were reduced to 50% of baseline after the fatigue
protocol, it is thought that HMB supplementation decreased the recovery time of muscle
damage, rather than influenced the amount of muscle damage that occurred in the postsupplement limb. An explanation of this reduced recovery time could be that HMB
supplementation increased the repair or resynthesis process of the damaged proteins or
structures that occurred in the eccentric fatigue protocol.
The current study showed that the MVC torque in the post-supplement limb
recovered faster when compared to the pre-supplement limb. This could be explained
by a positive effect of HMB supplementation but, it could also be a result of the baseline
MVC torque being significantly different between the two limbs. At baseline the MVC
torque for the post-supplement limb was 5.7 Nm less than the pre-supplement limb.
Since the post-supplement limb’s baseline MVC torque was lower, it may have been
easier and therefore faster for MVC torque to return to non-significant levels after the
fatigue protocol. This may have contributed to the post-supplement limb’s faster
recovery in the current study.
After the fatigue protocol, both the pre-supplement limb and the post-supplement
limb had a significant relative TA EMG deficit which was still present after 20 minutes of
recovery (Figure 4.5). This decrease in TA EMG may have been due to central fatigue,
high frequency peripheral fatigue, or a combination of both factors. The postsupplement limb showed no relative TA EMG deficits at the 48-hour recovery
measurement time and the pre-supplement limb still had relative deficits at the 48-hour
and 96-hour recovery measurement times. This is evidence that HMB supplementation
positively affected the recovery of the TA EMG in the current study. The current study is
52

in agreement with another study that saw a decrease in EMG activity in the forearm
flexors after an eccentric fatigue protocol (89). In addition, it has been reported that
EMG amplitude declines during maximal isometric contractions (23). This decline could
be due to decreases in motor unit firing rates, neuromuscular propagation failure, or the
slowing of conduction velocity (23). The current study is not in agreement with two other
studies that saw increases in EMG activity in the hamstring muscle group (33) and the
biceps brachii after an eccentric fatigue protocol (67). It was suggested that the
increased EMG activity was due to greater recruitment of motor units and an increased
motor unit discharge rate (67). The current study did not see an increase in EMG
activity of the TA muscle after the fatigue protocol. This may be due to the increased
central fatigue experienced by the subjects.
In conclusion the current study demonstrated that three weeks of HMB
supplementation reduced the effects and time course of LFF after an eccentric fatigue
protocol in the TA muscle. The 10/50 Hz torque ratio and the 10 Hz peak torque
recovered faster in the post-supplement limb when compared to the pre-supplement
limb. In addition, the MVC torque in the post-supplement limb may have recovered
faster when compared to the pre-supplement limb. This study also supports the
literature that there are two components of fatigue after an exercise bout, LFF that has a
long time course lasting longer than 96 hours and a fast recovering high frequency
fatigue. Since HMB supplementation has been shown to reduce LFF caused by
eccentric muscle contractions it may provide quicker recovery from physical activity for
recreational athletes, the general public, and people suffering from long term illnesses.
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Chapter VI: Summary

Introduction
Muscular fatigue, defined as a failure to maintain a required or expected
force/power for a given task, is a common result of physical activities ranging from
athletic performance to activities of daily living (31). Low frequency fatigue (LFF) is
muscular fatigue that occurs between 5 and 30 Hz stimulation frequency (34). The
characteristics of LFF include decreased muscle force that is most severe at low
stimulation frequencies, slow recovery of force that may take hours or days to resolve,
and the presence of force decrements may remain in the absence of gross metabolic or
electrical disturbance of the muscle (2, 3, 25, 34). This form of fatigue may be present
following any form of intense exercise and is a large contributor to the feeling of muscle
weakness after exercise (25, 84). The primary characteristic of LFF is the reduction of
muscle force at low stimulation frequency and this reduction of force is typically greater
than 50% of rested (baseline) values (25). Motor unit discharge rates during voluntary
skeletal muscle activation rarely exceed 30 Hz, therefore, most voluntary muscle
contractions may be substantially affected by LFF including any strenuous activity,
walking, stair climbing, and all other activities of daily living (25).
It has been previously demonstrated that one of the causes of LFF is a reduction
in the amount of calcium (Ca2+) released from the sarcoplasmic reticulum (SR) (2). A
decrease in Ca2+ release affects muscle tension at low frequencies of stimulation to a
much greater extent than muscle tension at high frequencies (25, 84). It seems likely
that there is some degree of structural damage to one or more of the proteins or
structures involved in excitation contraction coupling (E-C coupling) and the long time
course of LFF represents repair or re-synthesis of these proteins or structures (25, 84).
In support of this muscle damage explanation it has been shown that LFF frequently
occurs following eccentric exercises, and this LFF remains during the repair process if
the muscle fiber was damaged during the eccentric exercise (25).
Eccentric muscle contractions produce more muscle damage than concentric or
static contractions (2, 6, 61). These types of contractions are part of activities of daily
living including walking downstairs or lowering a heavy weight. It is believed that the
greater muscle damage caused by eccentric contractions is due to mechanical insult and
not metabolic fatigue (6). In overstretched sarcomeres the sarcoplasmic reticulum could
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be damaged or its connection with the transverse tubules (T-tubules) might be altered
(2) . Potential evidance for this is the reduction in force at low stimulation frequency
following eccentric muscle contractions (6). This LFF has been found to be caused by
E-C uncoupling and in particular a reduced amount of Ca2+ release from the SR (2, 6,
61, 83).
Supporters of a nutritional supplement, β-Hydroxy-β-Methylbutyrate (HMB)
supplementation, claim that HMB supplementation prevents muscle damage or
enhances the regeneration of damaged muscle cell membranes. However, no research
has evaluated the effect of HMB supplementation on low frequency fatigue. Therefore,
the purpose of this study was to determine if three weeks of HMB supplementation could
attenuate the effects of low frequency fatigue caused by eccentric muscle contractions of
the tibialis anterior muscle. It was hypothesized that HMB supplementation would
reduce LFF and enhance recovery after an eccentric exercise protocol. Therefore, this
study investigated the effects of three weeks of HMB supplementation on neuromuscular
performance, following fatiguing exercise, in healthy subjects.
Research Questions and Hypotheses
The first research question that this study sought to answer was: Are there
different types of muscle fatigue after an eccentric fatigue protocol in the TA muscle? It
was hypothesized that there would be two distinct types of fatigue after the eccentric
fatigue protocol. This will include a high frequency fatigue, measured by the 50 Hz peak
torque which will recover faster than the low frequency fatigue, measured by the 10 Hz
peak torque. This hypothesis was based on prior research that showed that there were
two groups of fatigue after activity and they were low frequency fatigue (LFF) at 5 to 30
Hz and high frequency fatigue at 50 to 100 Hz (35). In addition, high frequency fatigue
recovers very quickly usually within minutes after stimulation or exercise has stopped
and LFF where recovery of force is slow, taking hours or days (35).
The second research question that this study sought to answer was: Does HMB
supplementation have any effect on the recovery time of LFF following eccentric
exercise? It was hypothesized that HMB supplementation would reduce the recovery
time of low frequency fatigue following eccentric exercise. The 10/50 Hz torque ratio
and 10 Hz peak torque would recover toward baseline levels faster in the HMB
supplemented limb. This hypothesis was based on prior research that reported that
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HMB supplementation prevents muscle damage and/or aids in regenerating damaged
muscle cell membranes (26, 43, 46, 53, 66, 88).
The final research question that this study sought to answer was: Does HMB
supplementation have any effect on the recovery time of muscle damage caused by
eccentric exercise? It was hypothesized that HMB supplementation would reduce the
recovery time of muscle damage caused by eccentric exercise. As demonstrated by a
faster return of MVC torque to baseline in the HMB supplemented limb. This hypothesis
was based on prior research that reported that HMB supplementation imparted
anticatabolic properties and reduced muscle damage based on reduced enzyme
markers of muscle damage such as creatine phosphokinase (CK), lactate
dehydrogenase (LDH), and 3-methylhistidine (3-MH) (17, 21, 55, 70). In addition, HMB
was reported to be converted into β-hydroxy-β-methylglutarate-CoA (HMG-CoA) and
employed in cholesterol synthesis (26, 40, 50). Without cholesterol, cells cannot
experience normal growth or recovery (90). Supplemental HMB therefore, may be a
source of HMG-CoA in damaged muscle cells to maintain adequate cholesterol
synthesis and allow for maximal cell growth, function, and recovery (41, 71).
Discussion
The major finding of this study was that HMB did attenuate the effects of LFF
caused by eccentric muscle contractions in the TA muscle. This positive finding was
supported by the results that demonstrated that the 10/50 Hz torque ratio, and 10 Hz
peak torque in the HMB post-supplement limb recovered faster when compared to the
pre-supplement limb. In addition, it was observed that the MVC torque in the postsupplement limb recovered faster when compared to the pre-supplement limb. The
current study may be evidence that supports HMB’s ability to regenerate damaged
muscle cell membranes. This is based on the faster recovery of the 10/50 Hz torque
ratio, 10 Hz peak torque and MVC torque that was seen in the post-supplement limb in
the current study.
The 10/50 Hz torque ratio is a measure of LFF, and any significant reduction in
the 10/50 Hz torque ratio following completion of a fatigue protocol, is interpreted as LFF
(60). The 10/50 Hz torque ratio for the post-supplement limb recovered faster when
compared to the pre-supplement limb (Figure 4.4). The post-supplement limb was
recovered at the 48-hour recovery measurement time and the pre-supplement limb was
not recovered at the 96-hour recovery measurement time. Based on the 10/50 Hz
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torque ratio, the pre-supplement limb was still showing significant LFF at the 96-hour
recovery measurement time. In contrast, the post-supplement limb recovered faster,
and at the 48-hour recovery measurement time it was no longer showing significant
signs of LFF. This is evidence that HMB supplementation positively affected the time
course of LFF after the fatigue protocol.
The 10 Hz peak torque represents low frequency muscle stimulation and in the
current study it was used as another indicator of LFF. After the fatigue protocol, and
following the 20-minute recovery period, both the pre-supplement limb and the postsupplement limb had a significant relative 10 Hz peak torque deficit (Figure 4.2). In the
current study, based on the peak 10 Hz torque, there was still significant LFF observed
in the pre-supplement limb 96 hours after the fatigue protocol (Figure 4.2). In contrast,
the 10 Hz peak torque was recovered to non-significant levels in the post-supplement
limb at 48 hours after the fatigue protocol. This is more evidence that HMB
supplementation reduced the recovery time of LFF in the current study.
Based on these findings HMB supplementation may be beneficial to athletes,
recreational athletes, elderly, and anyone who participates in physical activity. This
supplement would be most beneficial to people who experience high levels of muscle
damage and LFF during physical activity. This would include sedentary people starting
a physical activity program or active people changing their physical activity program. In
these cases the potential for muscle damage and LFF is high and HMB supplementation
may help these individuals recover more quickly from physical activity. This supplement
would not be beneficial to individuals who are active and not changing their programs.
This is because the potential for muscle damage and LFF would be low and HMB
supplementation would not help these individuals recover from physical activity faster.
The 50 Hz peak torque represents high frequency muscle stimulation and in this
study it was used as an indicator of high frequency fatigue. At the end of the fatigue
protocol, both the pre-supplement limb and the post-supplement limb had a significant
relative 50 Hz peak torque deficit (Figure 4.3). During the 20-minute recovery period the
50 Hz peak torque increased in both limbs. By the 48-hour recovery measurement time
the 50 Hz peak torque had recovered to non-significant levels in both limbs. This is
evidence that high frequency fatigue recovers faster than LFF. There were no
differences between the pre-supplement and post-supplement limbs in the 50 Hz peak
torque measurement during the fatigue protocol, or any recovery measurement times.
Therefore, based on the 50 Hz peak torque measurement it is concluded that HMB
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supplementation had no effect on high frequency fatigue in the current study. At the 20minute recovery measurement time both the pre-supplement and post-supplement limbs
had a significant relative MVC torque deficit (Figure 4.1). Since both the pre-supplement
and post-supplement limbs were still significantly different from baseline, after 20
minutes of recovery, it is concluded that HMB supplementation had no effect on short
term muscle fatigue. Future research should focus on nutritional supplements that
enhance performance and reduce the amount of force loss during a fatiguing protocol. If
such a supplement can be found then high frequency fatigue and force loss would be
reduced during physical activity and performance would increase.
The MVC torque in the post-supplement limb also recovered faster than the presupplement limb at the 48-hour and 96-hour recovery measurement times (Figure 4.1).
This is an indicator that a degree of muscle damage was still present in the presupplement limb at the 96-hour recovery measurement time. Since the post-supplement
limb’s MVC torque was nearly fully recovered after 48-hours of recovery, this study
suggests that there was a positive effect of HMB supplementation on muscle damage
during the recovery time after the fatigue protocol. An explanation of this reduced
recovery time could be that HMB supplementation increased the repair or resynthesis
process of the damaged proteins or structures that occurred during the eccentric fatigue
protocol. This is more support that HMB supplementation may be beneficial to
individuals who experience high levels of muscle damage during their physical activity.
The current study showed that the MVC torque in the post-supplement limb
recovered faster when compared to the pre-supplement limb. This could be explained
by a positive effect of HMB supplementation but, it could also be a result of the baseline
MVC torque being significantly different between the two limbs. At baseline the MVC
torque for the post-supplement limb was 5.7 Nm less than the pre-supplement limb.
Since the post-supplement limb’s baseline MVC torque was lower, it may have been
easier for it to return to non-significant levels after the fatigue protocol. This may have
contributed to the post-supplement limb’s faster recovery in the current study.
Conclusion
The current study demonstrated that three weeks of HMB supplementation
reduced the effects and time course of LFF after an eccentric fatigue protocol in the TA
muscle. The 10/50 Hz torque ratio, and the 10 Hz peak torque recovered faster in the
post-supplement limb when compared to the pre-supplement limb. In addition, the MVC
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torque in the post-supplement limb may have recovered faster when compared to the
pre-supplement limb. This study also supports the literature that there are two
components of fatigue after an exercise bout, LFF that has a long time course, lasting
longer than 96 hours, and a fast recovering high frequency fatigue. Since HMB
supplementation has been shown to reduce LFF caused by eccentric muscle
contractions it may provide quicker recovery from physical activity for recreational
athletes, the general public, and people suffering from long term illnesses.
Future Research
The TA muscle used in this study is not a highly trained muscle and the subjects
used were only recreationally active. So, future research should be focused on HMB’s
ability to reduce the effects of LFF in other muscles and different populations, such as
highly trained, non-trained, and older populations. The quadriceps muscle group would
be a good muscle for future research in HMB’s ability to positively effect LFF and muscle
damage. This is because the quadriceps muscle group is a prime mover in many
activities and sporting events. Also, for the elderly population the quadriceps are the
main muscles in rising from a chair and locomotion.
Full training studies with HMB supplementation should be conducted to assess
its effects on the whole body during an exercise program. Since the current study
potentially supports HMB’s ability to increase muscle recovery from muscle damage, the
training studies should be designed to produce muscle damage. This could be done by
using a sedentary population starting a training program or a trained population that
would be drastically changing their program. A reason that some training studies did not
see any benefit of HMB supplementation could be because the training itself did not
cause significant muscle damage and LFF in the subjects used. In addition, these
studies should be of varying lengths to test HMB’s effects on reducing muscle damage
over different periods of time.
The current study supports HMB’s ability to reduce muscle damage but, no direct
measures of muscle damage were used in this study. So, future research, involving
HMB, should utilize some form of direct measure of muscle damage. This could include
muscle biopsies or measures of plasma proteins such as creatine phosphokinase,
lactate dehydrogenase or 3-methylhistidine. In these types of studies it could be shown
if HMB supplementation improves protein synthesis or decreases protein breakdown
after physical activity.
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